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ABSTRACT

A Proteomic Analysis of Differentiation in the Mammary Epithelium

Laura Therese Strand

While a great deal is known about the changing hormonal environment and the structural
development of the mammary gland from pregnancy to lactation, very little is known
about the molecular mechanisms governing differentiation of the mammary epithelium
into a milk-secreting phenotype. It is important to acknowledge the diversity among the
mammary glands of different species in order to better understand applications in human
health and the dairy industry. In this study, we examined global protein expression during
two states of differentiation in mammary epithelial cells from two species: in vitro
proliferating and differentiated MAC-T cells (a bovine immortal cell-line), and primary
mammary epithelial cells isolated from pregnant and lactating mice. When comparing the
lists of proteins that differed in abundance in the two experiments, we observed many
similarities in proteins related to structural dynamics and mRNA processing within these
two mammary epithelial cell types. Intriguingly, we observed several differences in the
regulation of metabolic proteins, highlighting the distinct pathways by which different
species probably metabolize energy and synthesize milk components.
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CHAPTER 1- Literature Review

1.1 Introduction

The words Mammalia and “mammary” are both derived from the Latin word mamma
meaning “breast”, so it is no surprise that the ability of the mammary gland to provide
nutrition for neonatal young is a defining factor setting this class of animal apart from
other vertebrates (Miriam-Webster, 2012). While most mammary related research has
been conducted in mouse models, it is important to acknowledge the diversity among the
mammary glands of different species in order to better understand applications in human
health and the dairy industry. Species-specific differences are not restricted to the
structure and tissue architecture and include differences in hormonal and metabolic
regulation of both development and lactation (Capuco, 2002). The purpose of this review
is to address some of these similarities and divergences as they apply to mammary
biology from development through lactation.

1

1.2 Mammary Structure/Architecture

The mammary gland is one of few organs in which the majority of development occurs
postnatally. It also has the unique ability to cycle from structural maturation through the
production of milk and an apoptotic regression to quiescence. Theoretically, this cycle
can repeat continuously from first estrus until menopause based on the number of
offspring and length of time the young are nursed (Knight, 1982).

The mature, non-lactating mammary gland consists mostly of stroma, or a structural
matrix of support provided by connective tissue, collagen and adipose tissue. Postnatally,
the fat pad is responsible for not only structural support, but also to provide the mammary
gland with contact to vasculature, the lymphatic system, lipids and local growth factor
synthesis (Hovey, 1999). The matrix provides the ideal environment for the branching
ductal system that makes up the region of the mammary gland responsible for the
synthesis and secretion of milk. The ductal mammary epithelium is made up of several
cell type subpopulations: a single layer of squamous, myoepithelial cells surround
cuboidal, luminal epithelial cells (responsible for synthesis and secretion of milk
components) and at the terminus of the ducts there are multiple layers of cells with the
stem-like ability to proliferate further or differentiate into secretory cells upon
establishment of pregnancy (Gjorevski, 2011). Throughout pregnancy the mammary
gland develops structurally and epithelial ducts culminate in the formation of alveoli.
Secretory alveoli are hollow sacs made up internally of a single-layer of cuboidal,
secretory epithelium connected by tight junctions (Delamaire, 2006). The surrounding
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outer layers of squamous myoepithelium are not secretory cells, but do have contractile
capabilities for the purpose of milk movement.

The fat pad surrounding these structures is not an inert element of the mammary gland. It
has been suggested that the presence of adipose tissue is not only paramount to the
formation of ductal structures, but also to the total milk yield potential of a gland; the
number of epithelial cells a gland contains is directly correlated with both the amount of
adipose tissue in the fat pad and the volume of milk a gland can produce (Hovey, 1999).
While the stroma of the mammary tissue does not secrete milk components, adipose cells
and connective tissue do contribute to lactation through structural support and paracrine
secretion of lactation signals. For example, when estrogen receptor alpha (ER-α) is
knocked down in the stroma, the epithelium remains under-developed due to the lack of
hepatocyte growth factor (HGF), which is normally secreted by adipocytes in response to
the binding of estrogen (E2) to ER-α (Gjorevski, 2011). Recent research indicates that
this “cross-talk” between the mammary fat pad and the expanding epithelium is necessary
for the development of the gland as neither stroma nor epithelium will function to its full
potential without the adjacency of the other (Berry, 2003).

3

1.3 Development

1.3.1 Overview

Although a rudimentary mammary gland exists from birth and expands structurally at
puberty, the mammary gland has not reached its full potential until it has functionally
developed milk-making machinery, which may allow a dam to independently support the
life of her offspring. This chapter will describe the stages of growth within the mammary
gland from fetal development, through pregnancy, as the gland prepares for the synthesis
of milk. Lactation, specifically the process of milk synthesis, will be described in depth in
the following chapter.

The term “mammogenesis” refers to the first stage of functional development during
pregnancy when the mammary gland begins to prepare structurally for lactation. This
growth is exponential until parturition and the onset of lactation (Knight, 1982).
Lactogenesis, or final differentiation of the extensively developed epithelium occurs in
two stages resulting in the functional milk producing machinery (Tucker, 1981). The first
stage of change within the epithelium is the increase in milk-related enzyme activity,
initiation of lipogenesis and the translation of milk proteins such as lactose, caseins,
alpha-lactalbumin and beta-lactoglobulin. Morpholigically, lactogenesis can be
distinguished by the formation of intracellular lipid droplets (Brisken, 2006). The second
stage of lactogenesis involves alveologenesis as tight junctions close between alveolar
epithelial cells and intracellular milk proteins and lipid droplets are secreted into the
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alveolar lumen due to the hormonal environment achieved through parturition and
stimulation (Foster, 1977).

Once lactation has begun, galactopoesis is the term associated with the maintenance of
lactation for a period long enough to nurture growing offspring and ends in involution,
the process of apoptosis of secretory cell types through the gradual weaning process and
the return to a quiescent state (Knight, 1982). Milk composition varies between species,
between individuals and within individuals but is not significantly affected by frequency
of milking or volume of milk produced (Delamaire, 2006). Galactopoesis can be
manipulated and extended through manual milking, a factor upon which the dairy
industry is based, however, the period of lactation is not indefinite and regardless of
frequency or milk yield, lactation will peak, regress and eventually cease (Amos, 1985).
Each of these developmental stages relies on the complex relationship between a variety
of hormones produced by the ovaries, anterior and posterior pituitary and locally within
the mammary gland (Perry, 2008).
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1.3.2 Embryonic Development

In the abdomen of a prenatal mammal, pairs of “placodes” (pre-organ regions of
thickened epithelium) form within the subcutaneous epithelial layer (Gjorevski, 2011).
Near the end of gestation, these placodes invaginate the adjacent mesenchyme so that at
birth, the mammary gland consists of a subcutaneous fat pad containing a very
rudimentary, branched ductal epitheilum (Mukhina, 2006). Fetal development of the
epithelium relies heavily on the adjacent inductive mammary mesenchyme that develops
in the mammalian embryo. However, this stage of development occurs even though the
rudimentary gland is deficient in receptors for any hormones typically linked with
postnatal development including estrogen, prolactin, growth hormone, progesterone or
growth factor receptors such as insulin-like growth factor-1 (IGF-1) and epidermal
growth factor (EGF) (Hens, 2005). This expansion without hormonal cues is poorly
understood, but further research may shed light on hormone resistant (i.e. ER-) mammary
gland cancer (Hens, 2005). The mammary mesenchyme does have the ability to respond
to androgens and it has been implicated as a possible target for sex hormones in the
process of sexual dimorphism and cessation of development in the male mammary gland
(Hovey, 1999). Prior to sexual maturation there is a period of allometric growth
providing a more complex matrix of structural support for a future functional mammary
gland (Mukhina, 2006).
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1.3.3 Pubertal Development

The pubertal transition, termed ductal morphogenesis, allows the ductal system to
permeate the stroma and fill the fat pad with a more elaborate branched epithelial system
(Mukhina, 2006). The puberty-associated shift in circulating ovarian hormones, such as
estrogen, cause extensive proliferation of the mammary gland epithelium to the limits of
the fat pad and the formation of quiescent boundaries identified as terminal end buds
(TEB) in mice. TEBs are multilayered structures surrounded by a basement membrane.
While ducts contain single layers of contractile myoepithelial cells and luminal epithelial
cells, the “cap” of the TEB contains multiple layers of cells with the stem-like ability to
proliferate further or differentiate into secretory cells upon establishment of pregnancy
(Gjorevski, 2011).

In humans, stem cells have been detected in the terminal ducts rather than the caps of
lobules. Mammary stem cells can become a variety of cell types depending on hormonal
cues and it has been demonstrated that one mammary stem cell has the ability to repopulate an entire gland (Gjorevski, 2011). The stem cell populations in the TEB end cap
of mice express a marker of multipotent stem cells called s-SHIP and the presence of
stem cells is imperative to the extension of ducts during puberty. Macrophages
eosinophils and mast cells, three immune cells, are also critical members of the mammary
gland stroma; without them, stem cells are unable to functionally re-populate the
mammary gland. While macrophages facilitate the action of stem cells by promoting the
formation of long collagen fibers around the base of the TEB, which are believed to
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support ductal elongation, mast cells induce branching of the mammary gland through the
secretion of serine proteases. The epithelium has been shown to secrete macrophage
colony-stimulating factor 1 (CSF1) and eotaxin, which may be responsible for the
recruitment of macrophages and eosinophils to the TEB (Gjorevski, 2011).

It is well-established that ovarian hormones play a role in mammary morphogenesis, but
there are species-related discrepancies over whether or not normal proliferating
mammary epithelial cells express ER or progesterone receptor (PR; Capuco, 2002). There
are two main subtypes of ER: ER-α and ER-β. In humans, cows, and rats, the ER is
localized to a subpopulation of non-proliferative epithelial cells, but studies in mice have
shown some evidence of ER+ proliferating cells and stromal cells (Capuco, 2002).
Estrogen, specifically estradiol (E2), is believed to be the main driver of ductal
elongation or longitudinal growth during puberty (Stingl, 2011). A review published by
Brisken, et al. (2006) considered data from several studies to illustrate that ER-α deficient
mice are completely infertile, but if ER-α is knocked out after sexual maturation, milk
proteins were still transcribed during pregnancy. These results indicate that ER-α is
necessary for mammary development during puberty yet may play a smaller role postpuberty and during lactation (Briskin, 2006). ER-β deficient mice have been shown to
develop ovarian defects and although they are able to lactate they express underdeveloped stroma and reduced milk secretion. Whether or not this is due specifically to
lack of epithelial E2 signaling or a symptom of general endocrine disruption, which
would be a likely complication of defective ovaries as E2 is not the only hormone they
secrete, has not yet been determined (Briskin 2006). Regardless, it is believed that E2 is
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exhibiting its proliferative effects on the whole epithelium mostly through paracrine
signaling through induction of amphiregulin secretion by ER-α + cells. Amphiregulin is a
known cell-growth modulator and shares a significant homology with EGF allowing it to
bind the EGF receptor (Shoyab, 1989).

Progesterone is the other key ovarian hormone associated with proliferation during
pubertal development, but it requires the presence of estrogen for maximal effects (Stingl
2011). In fact, expression of PR is autoregulated by both E2 and progesterone ligand
binding (Shyamala, 2002). Progesterone receptor abundance in the mammary epithelium
increases with puberty, but is only detected in approximately 55% of epithelial cells and
exclusively luminal epithelial cells, not in myoepithelial cells or surrounding stroma
(Shyamala, 2002). There are two isoforms of PR: PRA and PRB. These receptors are
derived from transcription of the same gene, differing due to two distinct promoters
leading to overlapping, but distinct sequences. The longer form (PRB) contains an
additional 164 amino acids termed the “B-upstream region” at the N-terminal end of the
protein (Gadkar-Sable, 2005). PRB is the predominant receptor responsible for mediation
the action of progesterone within the mammary gland during puberty, although PRA is
up-regulated upon initiation of pregnancy. (Briskin, 2006; Stingl, 2011). Progesterone
acts by inducing receptor activator for nuclear factor kb ligand (RANKL), which in turn
binds its receptor (RANK) and induces the side-branching or lateral spread of the ductal
system (Stingl, 2011).
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Development of the mammary gland does not rely on ovarian hormones alone, however,
as evidenced by studies concluding exogenous E2 treatment to be insufficient to rescue
branching of the mammary epithelium in animals that have had their pituitary gland
removed. Proliferation of the epithelium requires both growth hormone (GH), secreted by
the anterior pituitary, and insulin-like growth factor I (IGF-1) expressed by many tissues
in the body, one of which being the mammary gland (Capuco, 2002). Locally produced
IGF-1 from stromal cells, and associated binding proteins, may actually mediate the
exposure and response of the mammary epithelium to circulating GH and E2 (Akers,
2005). For example, in pubertal rodents, GH treatment has been shown to increase the
abundance of estrogen receptors as well as stimulating IGF-1 secretion from stromal cells
(Akers, 2005). The roles of E2, GH and IGF-1 do not end with puberty however. As
development of the mammary gland progresses, so do the varying roles for these
hormones.
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1.3.4 Development During Pregnancy

Gestational hormones stimulate further proliferation of the epithelium and ductal system
in the pregnant dam. In mouse mammary development the presence of estrogen and its
binding to nuclear ER-α is required for ductal morphogenesis, while progesterone acts
through RANK in the same manner as side-branching during puberty to induce tertiary
branching and alveolar development during pregnancy (Stingl, 2011; Asselin-Labat,
2010). In mice, alveoli, the hollow sacks lined with secretory mammary epithelium at the
termini of duct branches, are organized into clusters by day 16.5 of pregnancy (about ¾
of gestation period) but do not undergo functional differentiation, or lactogenesis of the
mammary epithelium until the end of pregnancy, around parturition (Brisken, 2006).
Milk components synthesized by the epithelial cells collect in the alveoli towards late
pregnancy and alveoli dilate and grow due to increased pressure. A distinct drop in
progesterone at parturition signals the secretion of milk components into the alveoli.
Oxytocin binding its receptors on the myoepithelium causes a contraction, which
squeezes the swollen alveoli pushing milk out through narrow ducts towards storage
sinuses (Rudolph, 2011; Lollivier, 2006). When oxytocin binds receptors on the luminal
epithelial layer of the alveoli, the effect is the acceleration of intracellular secretion of
casein milk proteins prior to myoepithelial contraction (Lollivier, 2006). Oxytocin in a
neuro-polypeptide hormone produced and secreted by the posterior pituitary gland under
many circumstances, one of which being parturition.

11

Prolactin is a pituitary polypeptide hormone detected in pregnant and lactating mammals
and has a tendency to spike dramatically just before parturition, playing a major role in
the second stage of lactogenesis (Tucker, 1981). A total deletion of the prolactin gene in
mice renders females infertile (Gallego, 2001) and without prolactin signaling within the
mammary epithelium alveogenesis will be incomplete and secretory differentiation will
fail to occur (Brisken, 2006). Prolactin is the major controller of lactogenic
differentiation, but it is supported synergistically by metabolic hormones such as growth
hormone, placental lactogen and adrenocorticotropin to promote milk synthesis and
secretion (Tucker, 1981). During lactation, prolactin is associated with cell survival,
glucose metabolism, and MEC-specific lipogenesis and beta-casein expression (Rudolph,
2011). More recent evidence suggests that the mammary gland itself has capabilities to
secrete and respond to paracrine and autocrine prolactin, growth hormone, leptin and
parathyroid hormone related peptide (Brisken, 2006). The prolactin receptor (PRLR)
signal cascade involves the JAK2/STAT5 pathway, resulting in the activation of several
transcription factors (including ELF5), which are related to the functional differentiation
of the mammary gland (Brisken, 2006). Outside of the mammary gland, PRLR activation
on pancreatic beta-islet cells causes proliferation and insulin secretion, which is related to
metabolic shifts required for milk production (Brisken, 2006).

There are species related differences in prolactin response. For example, as ruminant
breeding is closely associated with seasonal day-length, or “photoperiod”, a positive
effect relationship has been observed in heifers between extended photoperiods and
elevated prolactin secretion. Specifically, cows that calve in the fall had higher measured
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prolactin levels mid-pregnancy than cows that calved in the spring (Knight, 2001).
However, this significant difference in prolactin level during gestation does not
necessarily correlate to an increase in mammogenesis as in vitro studies have not shown a
mitogenic effect of prolactin on bovine mammary cells in culture (Knight, 2001).

In swine, the effects of prolactin are most crucial for mammary gland growth between
days 90 and 109 of a 115 day pregnancy even though the endometrium and placenta do
not secrete prolactin or placental lactogen as is observed in other species (Trott, 2009).
Administration of additional prolactin to sows did not contribute to further development
of the mammary gland, or increased nursing piglet weight leading researchers to believe
existing prolactin receptors (PRLR) are saturated with the naturally occurring prolactin
ligand concentration. These findings indicate the prolactin receptor as the limiting factor
on the effects of prolactin rather than the abundance of the hormone itself (Trott, 2009).

The PRLR does not only interact with prolactin, but also binds growth hormone (Xu,
2011). Both PRLR and GHR are transmembrane glycoproteins and members of the
cytokine receptor superfamily of G-coupled protein receptors and are highly conserved
across species (Xu, 2011). While GH has the ability to bind both receptor types, prolactin
only binds the PRLR. Both GH and prolactin play crucial roles in the mammary gland
from development through lactation.

Growth hormone (GH), or somatotropin, is a polypeptide hormone synthesized and
secreted mostly by the anterior pituitary somatotroph into the peripheral circulation,
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although more recent evidence suggests other cell types may secrete trace levels for
autocrine or paracrine signaling (Moffat, 1999). Secretion of GH by the pituitary is
regulated by peptides of hypothalamic origin. Growth hormone-releasing factor (GHRF)
is known to stimulate GH secretion while somatostatin inhibits secretion (Etherton,
1998). GH is made up of 191 amino acids, however, there are species differences and
even breed differences in amino acid sequence and subsequent structure that make the
GH of one species biologically inactive in another species due to receptor affinities
(Etherton, 1998).

While GH has many direct targets, such as muscle and bone, where it contributes to
growth as its name suggests, its indirect effects are more widespread when GH acts as a
signal for insulin-like growth factor 1 (IGF-1) secretion. Most systemic IGF-1 originates
in the liver as it is synthesized and secreted into the blood in response to GH. This
relationship between GH and IGF-1 is termed the “somatotropic axis” (Raccurt, 2002).
Some cell types, including those within the mammary gland, can synthesize either or both
GH and IGF-1 locally, possibly due to reliance upon these growth factors for
development and function.

IGF-I bioavailability and activity is regulated by insulin-like growth factor binding
proteins (IGFBP) through reservoir-type storage by extending the half-life of the
hormone or directing binding to specific tissue sites. Six high-affinity binding proteins
have been identified and the majority of circulating IGF-I in vivo is bound to IGFBP3,
IGFBP4 or IGFBP5 (Elis, 2011; Berry, 2001). The differing forms of IGFBP may play
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distinct roles in mammary development and involution (Berry, 2001). Levels of IGFBPs
have been demonstrated to vary based on hormonal changes in serum due to exercise,
diet, pregnancy and age (Elis, 2011).

Growth hormone has long been thought to act indirectly through IGF-1 signaling to
induce the elongation of ductal branches in the mammary gland as well as contribute to
the proliferation and differentiation of terminal end buds during puberty (Perry, 2008).
GH-null rats and GHR-null mice have both previously been shown to undergo impaired
mammary development in comparison to respective wild-types (Mukhina, 2006; Perry,
2008). This effect has been supported by one study that antagonized the natural GH
signal resulting in impaired mammary development in mice, and the rescue of mammary
development in GH-null rats by administering exogenous GH (Perry, 2008). These
studies indicate a necessary relationship between GH and the proliferation stage of the
mammary gland although the authors did not determine whether or not there may be a
direct relationship versus mediation by IGF-1 alone.

With a structure very similar to growth hormone, placental lactogen (a.k.a chorionic
somatomammotropin) is secreted by the placenta and is known to stimulate lipolysis and
antagonize insulin action allowing for more energy availability for the fetus while
contributing to mammary development during pregnancy (Picciano, 2003).

At the end of pregnancy, the normal mammary gland has undergone all preparation to
feed the growing offspring, and the act of parturition itself and the suckling of new young
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both contribute to the ejection of stored milk. The specifics of which will be explored
further in the following section.
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1.4 Lactogenesis

1.4.1 Overview

Although the composition of milk varies depending on a variety of factors including
species, breed, individual and even milking event, milk is generally made up of water
containing lipids, proteins, amino acids, vitamins, minerals, immunoglobulins, hormones,
cytokines, enzymes and other peptides essential for the growth of mammalian young
(Haug, 2007). While lactose and most minerals are water soluble, lipids exit the cell
emulsified in coated globules and milk proteins are suspeneded in micelles with calcium
or salts (Haug, 2007). Early mammary secretion (first 3-5 days post partum in humans) is
termed “colostrum”, a viscous substance rich in minerals, antibodies and other immune
factors including lactoferrin and secretory immunoglobulin A (Picciano, 2003). White
blood cells and specifically B and T lymphocytes within colostrum and mature milk
contribute significantly to building the immune system of the neonate (Larson, 1979). As
colostrum transitions to mature milk, there is a decrease in mineral and protein content
and an increase in water and lactose (Picciano, 2003).

Major differences between ruminant and non-ruminant milk production are due in part to
the dietary differences between species and the contribution of gastrointestinal flora to
the circulating nutrient pool available to the mammary gland for milk synthesis. While
most ruminants naturally consume large quantities of feed high in cellulosic, indigestible
fiber, microbe populations maintained within the anaerobic rumen environment ferment
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these carbohydrates into volatile fatty acids (VFA) which are absorbed by the host
ruminant. As microbes expire they are digested by the animal providing an additional
source of protein to be absorbed in the gastro intestinal (GI) tract (Van Soest, 1994). In
general, ruminant animals maintain much lower levels of circulating glucose compared to
non-ruminants due to this dietary process and therefore use VFAs as an alternative form
of energy wherever possible. For example, during late gestation 55% of ruminant fetal
energy is taken up as amino acids while only 30-35% is supplied by glucose (and
subsequent metabolite, lactate) (Bell, 2000). The remaining energy is supplied in the
form of acetate. Depending on their diet, rodents and other hind-gut fermenters, also have
the ability to absorb VFAs produced through the activity of caecal microbe populations
and may also contribute microbial VFAs to milk synthesis (Morishita, 1996).

High-yielding dairy cows ingest less energy than they expend at the start of milk
production, classifying this state as a negative-energy-balance (Kuhla, 2011).
Consequently, they must mobilize fat, glycogen, and muscle protein to meet energy output requirements and the breakdown of skeletal muscle becomes the primary source for
essential amino acids (EAAs). Loss of body protein in early lactation may amount to
approximately 20 kg per day in some dairy cows (Kuhla, 2011). It has been suggested
that the free AAs in circulation due to skeletal muscle breakdown may trigger a loss of
appetite, even in a state of negative energy balance. Feed intake in dairy cattle decreases
as they approach parturition, and only slowly increases to finally reach a state of positiveenergy-balance after 8 to 12 weeks of lactation (Bauman, 2000).
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Rodents on the other hand experience a gradual increase in the lactational demands of
nursing pups, and so feed intake is gradually increased proportionally to the growth and
number of pups. This increase can be up to 300-400% compared to feed intake prior to
pregnancy and lactation, but can meet the nutritional requirements for the output without
requiring the loss of body stores as observed in ruminant species (Bauman, 2000).
Human young demand a comparatively modest volume of milk for adequate nutrition
when compared to other mammalian species; normal human lactation should rarely result
in a negative-energy-balance (Bauman, 2000).

On the cellular level however, milk ejection is rather similar between species. Cuboidal,
secretory epithelial cells form the closest contact possible between adjacent cells, which
are termed tight junctions. Tight junctions function both as a barrier and as a gate, as
during lactation they mediate the transport of small molecules and ions between cells
while maintaining polarity within the cells for the maintenance of ion pumps and
channels (Delamaire, 2006). Ejection of milk components from the epithelium is a result
of osmotic pressure build-up as lactose and other minerals accumulate, drawing
additional water into the cells. There are gap junctions between adjacent cells that may
allow for some exchange of small molecular signal proteins, contributing to the
synchronized ejection of milk components from the epithelium into the lumen of the
alveolus (Larson, 1979).

As milking decreases, or weaning occurs, the composition of milk contains fewer
nutrients than milk from earlier lactation (Delamaire, 2006). This gradual change is
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caused by the “loosening” of the tight junctions allowing for greater permeability and a
decreased uptake of milk precursors by epithelial cells. The synthesis of individual milk
constituents will be discussed further within this review.
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1.4.2 Protein Synthesis

A crucial component of milk for the growth and survival of young is the supply of amino
acids, minerals and antibodies delivered by milk proteins. The majority of milk protein
consists of four casein proteins (α-s1, α-s2, β and κ) and whey proteins (α-lactalbumin and
β-lactoglobulin). Although less abundant, milk also contains transferrin and lactoferrin,
immunoglobulin IgA, lysozyme, and serum albumin (Jenness, 1979). Bovine milk is
widely commercialized as a nutritious food source for human consumption and contains
an average of 32g of protein per liter, 80% of which is casein. Casein forms micelles with
calcium and phosphorus for efficient transport of these minerals to the digestive system
once ingested (Haug, 2007). The most abundant casein protein in human breast milk is
homologous with the bovine milk protein beta-casein (Jenness, 1979).

Blood proteins and milk protein precursors (i.e. amino acids) enter the secretory, lobular
mammary epithelial cells through the basal membrane, which is in direct contact with the
basement membrane of the extracellular matrix separating the epithelium from the blood
stream (Larson, 1979). Milk proteins are coded for by messenger RNA (mRNA) exported
from the nucleus and capped on the 5’ end. At the 3’ end of milk protein mRNA there is a
tail of multiple adenylyl nucleotides (a “poly (A)-tail”), which aids in translation and
protects against mRNA degradation (Rhoads, 2007). Each set of 3 nucleotides codes for
an individual amino acid, which is recruited to the ribosome bound to a complementary
transfer RNA (tRNA). The ribosome translates mRNA into peptide chains of amino acids
on the endoplasmic reticulum. From here, long, polypeptide chains are transported to the
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Golgi apparatus where glycosylation and phosphorylation occur along with the coupling
of calcium to casein micelles. Tertiary folding and accumulation of micelle structure is
completed before fully formed milk proteins are ejected through the apical membrane of
the epithelial cell into the lumen of the alveolus through transport by secretory vesicles
(Larson, 1979).

Lactogenic hormones (prolactin, insulin, glucocorticoids) have great control over the
regulation protein synthesis by the mammary gland not only by stimulating transcription
of mRNA coding for milk protein genes, but also by stabilizing mRNA and extending the
half-life for more efficient translation (Rhoads, 2007). The translation of milk proteins is
then stimulated by a synergy between available amino acids and insulin and prolactin
signaling (Rhoads, 2007). In the presence of lactogenic hormones, the mammary
epithelial cell selectively polyadenylates milk protein mRNA in the cytoplasm elongating
the poly(A)-tail for enhanced translation (Rhoads, 2007).

The availability of amino acids to the mammary gland for milk synthesis is based
primarily on dietary intake, but also gastrointestinal and hepatic utilization of amino acids
(Bequette, 1997). During lactation, ruminants specifically experience a surprisingly low
efficiency of dietary amino acid conversion to milk protein. In fact, the levels of certain
free-form essential amino acids (EAA) absorbed from the circulation by the mammary
gland have been measured to be insufficient for the amount of milk protein secreted. This
deficiency must be met by breaking down formed proteins that contain the necessary
EAAs, sometimes sacrificing muscle tissue (Bequette, 1997). Other amino acids, whose
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absorption is greater than output as milk protein --leucine is an example-- are not taken
from protein-bound sources (Bequette, 1997). When additional free-form dietary amino
acids are administered, the mammary gland has a higher affinity for these sources than
the protein-bound sources, which require extra energy to break down. This illustrates the
adaptability of the gland to changes in supply and demand.
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1.4.3 Lactose Synthesis

The disaccharide lactose is the main osmotic agent drawing water into milk and due to
this, lactose synthesis contributes significantly to milk yield. Lactose is the most
abundant carbohydrate found in milk contributing nearly half of the caloric content
required by the infant and synthesized from glucose and galactose within the Golgi
apparatus (Sunehag, 2003; Anderson 2007). The synthesis of this particular sugar is
unique to the mammary epithelial cell due to the expression and activity of lactose
synthetase, a heterodimer made from milk protein alpha-lactalbumin and its interaction
with Golgi-bound glycosyltransferase beta-1,4-galactosyltransferase (Anderson, 2007;
Shaper, 1998). In dairy cattle, 55-70% of glucose taken up by the mammary gland is used
for the synthesis of lactose (Guinard-Flament, 2006). Eighty to 85% of the carbon in
bovine milk lactose is derived from glucose because more than half of the galactose
required for lactose synthesis is actually a converted product of glycolysis. This
production involves conversion of glucose 6-phosphate to galactose by the enzymes
glucose phosphorylase and glucose 4 epimerase (Sunehag, 2003). Additional galactose
can be synthesized from glycerol, and some studies suggest the lactating mammary gland
has the enzymatic capacity to produce glucose-6-phosphate from other 3-carbon
substrates, a process characterized within the human breast and termed hexoneogenesis
(Sunehag 2003). The percentage of plasma glucose-derived lactose is higher in nonruminants with greater dietary glucose intake and during a fed state as opposed to fasting
(Anderson, 2007).
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Glucose pays a critical role in lactation for both ruminants and non-ruminants although
the availability of glucose to the gastrointestinal tract, and subsequently the circulation, is
much lower in the ruminant due to rumen fermentation. In addition, the fate of glucose in
the mammary epithelial cell differs slightly between the two mammalian metabolic
systems. Overall, this monosaccharide is necessary for the synthesis of lactose, metabolic
energy (ATP production), glycerol production for de novo fatty acid synthesis, and
NADPH production through the pentose phosphate pathway (Van Soest, 1994; GuinardFlament, 2006). Additionally in non-ruminants, glucose is the main precursor fatty acid
synthesis as will be discussed in chapter 1.3.4.

Because the mammary epithelium does not possess the necessary enzymes for
gluconeogenesis, all glucose utilized by this organ must be taken up from the circulation.
Glucose enters the mammary epithelial cell via the GLUT1 transporter, an insulin
independent transporter. In dairy cows, the mammary gland has been known to use up to
85% of total circulating glucose, although published research states that the GLUT1
transporters on ruminant mammary epithelial cells are probably never saturated under
normal physiological conditions (Zhao, 1996). Once inside the cell, if directed towards
use as an energy source, glucose is converted to glucose-6-phosphate by the enzyme
hexokinase (Rudolph, 2011; Salway, 1994). From this point, glucose-6-phosphate can be
a precursor for either glycolysis and the tricarboxylic acid cycle (TCA) or the pentose
phosphate pathway providing energy for fatty acid synthesis.
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1.4.4 Lipid Synthesis

Although “reduced-fat” and “non-fat” dairy products have increased in popularity for the
adult human consumer, the neonate would not survive without milk fat. The
concentration of fat in milk varies between species and the needs of their young, but on
average, 95-98% of the lipid content in milk is triacylglycerols made up of fatty acids of
differing lengths and levels of saturation (Haug, 2007). The remaining 2-5% of lipids are
made up of diacylglycerol, cholesterol, phospholipids and free fatty acids (Haug, 2007).
Triacylglycerol is synthesized by the joining of long or short chain fatty acids to a
glycerol backbone. Once a molecule is complete it combines with other fully-formed
TAG to make lipid globules that increase in size as they are translocated to the apical
surface of the epithelial cell where they are surrounded by the apical membrane which is
pinched off and emulsified in milk (Larson, 1979). Milk fat can be made from fatty acids
stored in adipose tissue, diet, or through de novo synthesis and carried through the
circulation to the mammary epithelium bound to albumin or very low-density
lipoproteins (VLDL). Ruminant milk is unique in that it contains a high proportion of
short-chain (between 4 and 10 carbons) fatty acids even though these forms are not found
in non-ruminant milk or feed. This means ruminant milk fat is more often derived from
de novo synthesis or the desaturation of free long-chain fatty acids (Bauman, 2011). In
the non-ruminant mammal, glucose is the primary source of both glycerol and fatty acid
synthesis (Anderson, 2007).

Lipogenesis, or more specifically, de novo synthesis of fatty acids occurs mainly in the
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liver, adipose tissue and mammary gland of a lactating mammal (Laliotis, 2010). The
main precursor for this pathway is acetyl-coA, however, the source of acetyl-coA and the
primary location of lipogenesis is species specific. In humans, and most non-ruminant
animals, the majority of fatty acid synthesis occurs in the liver. Conversely, the lowglucose ruminant diet causes the ruminant to rely on the liver primarily for its
gluconeogenic capabilities, and the adipose tissue and mammary gland (during lactation)
are the sites, for the majority of de novo fatty acid synthesis (Laliotis, 2010). The main
energy sources delivered to the gut post-fermentation by the rumen are the volatile fatty
acids (VFA) acetate, propionate, and butyrate. Acetate is the basic building block for
fatty acid synthesis in ruminants, which requires NADPH as a reducing agent (Bauman,
2011).

As illustrated in figure 1, non-ruminants can utilize glucose for fatty acid synthesis.
Acetate and pyruvate can be oxidized to acetyl-coA within the mitochondria and
converted to citrate in order to be transported out of the mitochondria by the
citrate/tricarboxylate carrier (CiC). Through the action of citrate lyase, citrate can be
broken down into acetyl-coA and oxaloacetate outside of the mitochondria. Acetyl CoA
may then be used for fatty acid synthesis and oxaloacetate can then be converted to
malate and cycled back to pyruvate through the action of malate dehydrogenase. The
reaction producing pyruvate from malate provides an additional source of NAPDH for
the non-ruminant, but as illustrated in figure 2a, this enzyme is not active in the ruminant
mammary epithelial cell.
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Another difference in the ability of ruminant mammary epithelial cells to produce
NADPH is the lack of citrate lyase activity. As illustrated in figure 2b, citrate cannot be
converted to acetyl CoA or oxaloactetate, and therefore, there is no complete
pyruvate/malate cycle. Due to this factor, the TCA cycle cannot contribute to fatty acid
synthesis in the ruminant and NADPH must be produced by isocitrate dehydrogenase
(IDH) activity and the conversion of isocitrate to alpha-ketoglutarate in the cytosol or by
the pentose phosphate pathway (Salway, 1994).
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Figure 1. Fatty Acid Synthesis
This figure illustrates the alternate pathways and carbon sources utilized by ruminant
versus non-ruminant
ruminant animals for eventual participation in de novo fatty acid synthesis
within the mammary epithelial ce
cell.
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Figure 2. NADPH Production
NADPH is produced through the action of the pentose phosphate pathway, malate
dehydrogenase and isocitrate dehydrogenase, in the non
non- ruminant mammary epithelial
cell. Ruminant animals do not express the enzymes necessar
necessary
y for all of these reactions; as
illustrated in the bottom figure with crossed
crossed-out
out and shaded boxes, most NADPH in the
ruminant mammary epithelial cell must be produced via isocitrate dehydrogenase activity
and to a lesser degree, the pentose phosphate pat
pathway.
a.

b.
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1.4.4.1 Pentose Phosphate Pathway

The pentose phosphate pathway is active only in the liver, adipose, lactating mammary
gland, adrenal cortex and red blood cells in the mammal (Mellenberger, 2009). When
glucose is present in abundance and glycogen stores are full, excess glucose will be
stored as fat; a process which requires the products of the pentose phosphate pathway.
Mammary epithelial cells must also take advantage of this pathway when demand for
milk fat becomes a metabolic priority during lactation (Salway, 1994). The pentose
phosphate pathway produces NADPH, which can be used for biosynthesis of fatty acids
and cholesterol.

Glucose 6-phosphate enters the pentose phosphate pathway and is oxidized by glucose-6phosphate dehydrogenase to form 6-phosphoglucono-delta-lactone and NADPH.
Lactonase further hydrolyses the product into 6-phosphogluconate, which is oxidized by
6-phosphogluconate dehydrogenase to ribulose 5-phosphate and gives off CO2 and an
additional NADPH. This phase of the pathway is irreversible, the final product, ribose 5phosphate, can accumulate, and three molecules of ribose 5-phosphate be converted into
two molecules of fructose 6-phosphate and one molecule glyceraldehyde 3-phosphate.
Fructose 6-phosphate can be converted back to glucose 6-phosphate for re-entry into the
pentose phosphate pathway cyclically or re-entry to the glycolytic pathway. This pathway
is regulated by the availability of NADP+, which is readily abundant during fatty acid
synthesis, where NADPH is reduced (Mellenberger, 2009). Ruminant mammary tissue
only undergoes an increase in pentose phosphate activity of about 3 fold, while pentose
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phosphate activity in rodent mammary glands has been shown to increase by 15-80 fold
(Mellenberger, 2009). This is probably due to glucose being the substrate upon which this
pathway relies, and the relatively low levels of circulating glucose in the ruminant
system.
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1.5 Mammary Gland Models

Due to the endless complexity of a whole animal system, in vitro modeling has become
the preeminant approach to studying cellular function in a controlled manner that can be
manipulated experimentally (Matitashvili, 1997). Among the most commonly employed
mammary models are explant tissue, primary cell and immortal cell line cultures.
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1.5.1 Explant Culture

An explant culture consists of a small, three-dimensional tissue-sample that may be
excised from the mammary gland through biopsy or immediately following slaughter. As
a model, the explant is an excellent way to observe the interactions between all of the cell
types within the gland that may depend on structural relationships to function similarly to
in vivo (Keys, 1997). In addition, an effect observed in vivo can be validated in culture
when that tissue is separated from circulating ligands and systemic signals (Telang,
1989). Some drawbacks to explant culture (excluding xenografts) are: (a) the short life of
the tissue in culture as they are only viable for a few day at most (Keys, 1997); (b) the
mix of cell types within an explant, making study of the epithelium exclusively
impossible, and knowing the proportion of epithelial cells in the explant is a challenge;
(c) explants cannot be frozen cryogenically, so some experiments are not repeatable over
time with samples from a single isolation event. While explants from rodent mammary
glands have been used in experiments for over 50 years, conducting successful explant
studies with ruminant mammary tissue has presented a much greater challenge, and is
more narrowly studied (Matitashvili, 1997).
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1.5.2 Primary Cells

Primary cell cultures consist of a specific cell type isolated from tissue that may be
excised from an animal under the same conditions as an explant. Once tissue is excised it
can be minced, digested and strained to a single cell suspension, at which point differing
cell types can be separated through a variety of protocols including gradient cetrifugation
or plate adhesion incubation periods (Smalley, 2010). Primary cells can be isolated from
animals in different stages of development (i.e. pregnancy versus lactation) to control for
differences based on starting stage of the mammary cell (Matitashvili, 1997). Other
advantages to using primary cell culture are: (a) the ability to study a single cell type; (b)
primary cells secrete proteins and lipids directly into media which can then be measured
quantitatively; (c) primary cells can proliferate for a greater volume of samples and can
be kept in culture for extended periods provided the right combination of growth factors
and nutrients; (d) primary cells can be cryogenically frozen and used for future research
or to repeat an experiment at a later time, even with cells isolated from the same animal
(Keys, 1997). A few drawbacks are: (a) the necessity for validation that the intended cell
type was indeed the one isolated and cultured and the likelihood of a small percentage of
contaminating mesenchymal cells (Matitashvili, 1997); (b) an environment unlike the in
vivo environment, cryopreservation and extended passaging of cells may cause a change
in the cells morphology and function (Keys, 1997). Morphology and secretory activity
may also be affected by whether primary cells are plated on plastic culture dishes,
artificial extracellular matrices, or attached collagen gel (Matitashvili, 1997).
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1.5.3 Immortal Cell Lines

An alternative to these methods is the culture of an immortalized mammary cell line.
Several mammary epithelial cell lines from a variety of species have been used in
mammary biology research and all originate from primary cell isolation of normal or
tumor cell types (Matitashvili, 1997).

Commonly studied are immortal mammary epithelial cell lines that originate from murine
species. The COMMA-1D cell line, for example, has been used extensively in mammary
gland reasearch and was initially isolated from mid-pregnant BALB/c mice. Although
this line has been passaged continuously, it was never transformed and the mechanism
behind its immortality is somewhat unknown, even by scientists who initially
characterized the line (Danielson, 1984). These cells were assumed to be proginator cells,
or stem cells and due to their ability to populate a cleared fat pad with a normal
mammary structure as well as their inducible casein production in vitro they are
considered an excellent in vitro model for the mouse mammary epithelium (Danielson,
1984). The HC11 cell clone was later isolated from the COMMA-1D line due to the need
for a strain that would grow without an extracellular matrix or co-cultivation with other
cell types. The success of this isolation was confirmed through the expression of betacasein dependent upon treatment with prolactin when cultured on plastic (Ball, 1988).

Although there are many established cell lines that originate from mice, fewer lines are
readily available for bovine studies. One cell line, MAC-T, was developed by Huynh et
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al. through the stable transfection of alveolar epithelial cells from a mid-pregnant
Holstein heifer with the simian virus (SV)-40 large T anigen (TAg) (Huynh, 1991). The
SV-40 TAg is an oncoprotein (cancer causing protein) that inhibits the activity of tumor
suppressing factors p53 and retinoblastoma allowing the host cells to proliferate
indefinitely (Ali, 2001). MAC-T cells have the ability to differentiate to a “lactating”
phenotype when induced with a lactation medium including dexamethazone, insulin and
prolactin, defined by the fact that they can secrete milk proteins in culture (Huynh, 1991).
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1.6 Lactation & Breast Cancer

Breast cancer accounts for 1 in 4 female cancers and is by far the most common cancer in
women worldwide with rising incidence (Siewit, 2009; Moreira, 2010). Epidemiological
studies have recognized a relationship between early age of first full-term pregnancy and
total number of pregnancies with a reduced risk of breast cancer for nearly a half-century
(MacMahon, 1970). More recently, the relationship between mammary gland
development, lactation and its subsequent preventative effects are being studied in
clinical settings (Yogi, 2012). Although the post-lactational breast regresses to a state
very similar to the nulliparous breast, studies have shown that pregnancy induces some
permanent changes in gene expression within the mammary gland, specifically related to
DNA damage repair, enhanced immunity, and decreased cell proliferation (Russo, 2005;
Yogi, 2012). The end of lactation signals a regression of the functional gland that
includes massive apoptosis leaving just a few stem cells to repopulate the gland upon
future pregnancy. These parous stem cells have been exposed to different hormones and
structural changes, making them epigenetically different and functionally different than
the stem cells populating the mammary gland during first pregnancy (Russo, 2005).
Additionally, mouse studies have shown that an early pregnancy can reduce the total
number of stem cells within the mammary gland without impairing their ability to
repopulate the gland (Visvader, 2009).
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1.6.1 Breast Cancer Biomarkers

Early detection and classification of breast cancer greatly improves the odds of the
survival of a patient, which makes the simplicity of screening and the identification of
biomarkers extremely important (Ou, 2008). The term “biomarker” is described by the
National Institute of Health as a cellular event in which expression signifies a specific
phenotype, in this case, cancer (NIH, 2011). Interestingly, transcription factor GATA-3
has been implicated as a gene driving luminal cell differentiation within the mammary
epithelium and expression of GATA-3 is also a biomarker and a determinant of breast
cancer patient prognosis (Visvader, 2009). With higher levels of Gata-3 a tumor is more
likely to respond to treatment as it is associated with a more differentiated state and is
less likely to metastasize.

There are numerous ways in which biomarkers may be identified and each methodology
has both strengths and limitations. Methods based on existing hypotheses tend to favor a
narrower scope, focusing on a specific pathway thought to be affected by a carcinogenic
introduction.

For example, many tumor cells exhibit the “Warburg effect” or the

heightened consumption of glucose causing a build-up of lactate through anerobic
gycolysis and reduced use of the TCA cycle (Levine, 2010). Since its discovery in 1926,
this pathway has been compared between tumor cells and normal cells of the same tissue
to implicate a few oncogenes and tumor-suppressing genes. A deeper understanding of
these genes implicated may be useful in developing targeted gene therapies in cancer
treatment (Levine, 2010). A major drawback to studying this narrow scope of genes on
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the transcriptional level is the lack of correlation between gene expression and protein
expression, with recorded differences as high as 30-fold (Ou, 2008). Additionally, there
are post-translational modifications and cellular localization events that totally change the
function of a molecule, which are not detected by quantitative mRNA expression profiles.
An alternative method is to employ a discovery technology or hypothesis-generating
approach such as proteomics, the results of which can be compared with transcriptional
data to implicate specific genetic biomarkers.
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1.7 Summary

The exocrine mammary gland is an organ of great complexity with a synchronous
relationship to endocrinology and metabolism. It is this systemic involvement makes this
organ, and the cells of which it is comprised quite difficult to study exclusively, yet a
deeper understanding may provide insight into the treatment and prevention of cancer and
the nutritional optimization and production efficiency of the dairy industry. Instead of
approaching the holes in our knowledge of this gland by focusing on the pathways we
already expect to be involved, research into development of the mammary gland may
benefit from a more global approach. As “omic” technologies are improving rapidly, and
transcript and protein databases are expanding with new research, our lab has developed a
curiosity in the application of these technologies to gain further knowledge on
differentiation of the mammary epithelium.

Through the application of literature review to our experimental analysis, we hope to
provide novel insight into cellular mechanisms that may be involved in the differentiation
of mammary epithelial cells from a proliferation stage to lactation. Moreover, we hope to
approach this question by taking into consideration the whole-animal species differences,
from diet and metabolism to needs of the young that may be applicable to the developing
mammary epithelial cell.
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CHAPTER 2 – Proteomic Analysis of Differentiation in the MAC-T Cell Line

2.1 Introduction

Previous research within our lab has demonstrated an effect of growth hormone (GH) on
the proteomic profile of differentiated bovine mammary epithelial cells (MEC) of the
immortal cell line MAC-T*. MAC-T cells can be differentiated in vitro through treatment
with a classic lactation medium containing dexamethosone, insulin and prolactin at the
point of confluence (when cells completely coat the surface upon which they are plated)
and are known to retain many of the characteristics of bovine MEC (Huynh, 1991). The
proteins that changed in response to GH treatment were related to glucose metabolism,
NADPH production, cytoskeletal changes and RNA processing which led us to believe
the effect of GH may cause changes that are similar to those which occur during
differentiation events. If true, GH would be implicated as a possible factor in mammary
epithelial cell differentiation, which contradicts current dogma of the role of GH within
the mammary gland (Zhou, 2008).

In order to assess the results of the GH study and its association with differentiation, there
must be a control study with which to compare. The obvious control is to observe
changes in global protein expression that occur within the epithelium over the process of
differentiation in MAC-T without growth hormone treatment. We went about this
observation by comparing protein extracts isolated from cells still proliferating in vitro
*

Thesis research by Tasha Johnson, 2010. Publication in progress.
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and cells that had been differentiated to a “lactating” phenotype for a period of 7 days.
Although there have been previous attempts to develop protein expression profiles for a
“normal” mammary epithelial cell, few have considered the global changes that occur
throughout the process of differentiation (Desrivieres, 2003). There are likely major
differences, to be considered as well, between protein expression in human and murine
MEC versus those of ruminant (specifically bovine) origin as there are major differences
in metabolism, fat storage, and milk synthesis between the species (Van Soest, 1994).

Proteomics is a discovery-based approach to molecular biology. By refraining from
attempting to quantify expected genes or proteins, proteomics allow us to draw back the
focus and identify total protein expression from a sample. From this point, we may
compare across samples from different treatments or developmental stages to create new
hypotheses for the molecular events taking place at the time of protein isolation. In this
way, unexpected discoveries may be made that can later be expanded upon and validated
through fine-tuned quantitative technologies. Transcriptomic technologies are highly
valuable in that they provide a wider array of genes on which to base hypotheses,
however, there is a high probability that many genes transcribed are never translated in
vivo (Ou, 2008). While a combination of both assay types would amount to a more
complex picture, the proteome depicts actual protein existence rather than relying on
assumptions based upon presence of mRNA alone, which is why we selected this
approach specifically.
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In this study, total protein was extracted from MAC-T cells during cell proliferation or
after seven days of differentiation, which should theoretically correspond with
established lactation in vivo, as this was the treatment period in the former study upon
which this experiment was based. Global protein expression was then visualized by twodimensional gel electrophoresis (2DGE) before identification of individual proteins that
changed significantly in abundance through matrix assisted laser desorption/ionizationtime of flight (MALDI-TOF/TOF) tandem mass spectrometry.
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2.2 Methods

All reagents were acquired from Sigma Aldrich (St. Louis, MO) unless otherwise noted.

45

2.2.1 Cell Culture

MAC-T cells were cultured on 10 cm plastic plates under growth medium (low glucose
Dulbecco’s Modified Eagle Medium with 10% FBS, 1% Penicillin/Streptomycin (PS),
1% Amphotericin B, 5ug/mL insulin, 1ug/ml progesterone), which was replenished every
48 hours until confluence at which point half of the plates were harvested for protein
extraction. Differentiation was induced in the remaining plates with lactation media (low
glucose Dulbecco’s Modified Eagle Medium with 10% FBS, 1% PS, 1% Amphotericin
B, 1ug/mL dexamethasone, 5ug/mL insulin, 5ug/mL prolactin). Differentiated cells were
cultured in lactation media replenished every 24 hours for an additional 7 days before
harvest.
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2.2.2 Protein Extraction

Media was aspirated from all plates followed by a 1ml rinse of sterile filtered phosphate
buffered saline solution (PBS). Cells from nine 10cm plates were pooled into three
microfuge tubes (n=3, 3 plates per 2ml tube). Cells were rinsed again with PBS by vortex
and centrifugation. Cells were lysed in 450ul lysis buffer (7M urea, 2M thiourea,
1%ASB-14, 40mM tris base, 0.1% IPG buffer and 40mM DTT) followed by three 10second pulses of sonication with a probe sonicator while microfuge tubes remained on
ice. Lysed cells were centrifuged at 4°C for 30 minutes at 10,400 x g. Supernatant
containing protein extract was frozen at -80°C.

Protein extracts were precipitated with a 10% TCA/acetone solution for 12 hours at 20°C. Samples were rinsed with 100% acetone and allowed to dry before rehydration by
working rehydration buffer (7M urea, 2M thiourea, 2% CHAPS, 2% Nonidet P-40,
0.002% bromophenol blue, 0.05% immobilized pH gradient (IPG) buffer and 100mM
DTE). Rehydration occurred over a 12 hour period at 4°C. Impurities were removed
through centrifugation and rehydrated protein extracts were stored at -80°C.

Protein concentrations were quantified using the 2D-Quant kit (GE Healthcare, Uppsala,
Sweden).
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2.2.3 Two-Dimensional Gel Electrophoresis (2D)

An 11cm IPG strip (pH 3-10) was used to separate 200ug of protein from each sample
through isoelectric focusing (Bio-Rad, Hercules, CA). IPG strips were actively
rehydrated for 12 hours and separated by isoelectric focusing using the Bio-Rad Protean
IEF cell preset 11cm rapid program (250V for 15 min, 8000V for 2.5 hours and 35000
vhours).

Proteins were separated in the second dimention, by molecular weight, on precast
Criterion 10% tris-HCl 11cm gels using a Criterion Dodeca Cell (Bio-Rad, Hercules, CA)
for 1 hour at 200V. All gels were run in duplicate.

Proteins were stained overnight with colloidal Coomassie Blue G-250 (Coomassie Blue
G-250, H2SO4, NaOH, glacial acetic acid and sterile water) and rinsed periodically with
sterile water until protein spots were clearly visible. Stained gels were scanned and
analyzed by Delta 2D gel image analysis software (DECODON, Germany). Spot
volumes were analyzed using a t-test based on a null distribution that was generated using
1000 permutations to account for unequal variance and non-normal distribution of the
data. Differences were considered significant at P < 0.01.
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2.2.4 Tryptic Digestion and MALDI TOF/TOF Mass Spectrometry

Protein spots were manually excised from 2D gels with a 1.5mm tissue arrayer puncher
(Beecher Instruments, Sun Prairie, WI) and stored at -80°C in 0.5ml microfuge tubes.

Coomassie blue was removed from the gel plugs by two 30-minute incubations on a
shaking plate with destaining buffer (25mM NH4HCO3 and 50% acetonitrile).
Destaining was followed by a wash with 100% acetonitrile and an overnight incubation at
37°C in trypsin digestion solution (1ug/ul mass spectrometry grade porcine trypsin gold
(Promega, Madison, WI) in 40 mM NH4HCO3 and 10% acetonitrile). Digested peptides
were eluted from gel plugs through two 30-minute incubations on a shaking plate with
analyte solution (0.1%TFA and 33% acetonitrile). Supernatants were moved to new,
0.5ml collection tubes after each incubation. Eluted peptides from each sample were
dehydrated in a 45°C speedvac centrifuge for 50 minutes and rehydrated in a matrix
solution (0.2mg/ml α-cyano-4-hydrocinnamic acid (HCCA) in acetonitrile). Each peptide
sample was plated individually on an anchorchip target (Bruker Daltonics, Billerica,
MA), washed with a rinse buffer (0.1% TFA in 10mM ammonium phosphate) and
recrystallized with a solution of ethanol, acetone, and 0.1% TFA (6:3:1). Each sample
was analyzed by ultraflex II MALDI-TOF/TOF mass spectrometry (Bruker Daltonics,
Billerica, MA) and peptide mass fingerprints (PMF) were acquired and externally
calibrated with FlexControl software (Bruker Daltonics, Billerica, MA). PMFs were
further analyzed using MASCOT server launched from BioTools software (Bruker
Daltonics, Billerica, MA) against the NCBI database. Carbamidomethylation and
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oxidation were set as fixed modifications for MASCOT searches with a maximum of one
missed cleavage. PMF were further analyzed using MS/MS spectra using five to ten of
the largest peaks per sample (excluding keratin and trypsin). Spectra were internally
calibrated and processed using FlexAnalysis software (Bruker Daltonics, Billerica, MA).
PMF and MS/MS spectra were combined and queried as described for PMF spectra
analysis using the MS/MS spectra.
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2.2.5 Protein Analysis

Estimated molecular weight and isoelectric point (pI) were calculated using ExPASy
Bioinformatics Resource Portal software (www.expasy.org) and cellular localization,
gene names and functions of proteins were acquired from the “UniProtKB” UniProt
Protein Knowledgbase (UniProt Consortium, 2012) unless otherwise noted.
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2.3 Results

Through the use of Delta 2D, 223 individual protein spots were identified on the
composite image of all gels. Of those 223, 82 spots (37%) differed in abundance between
the two treatment groups (p < 0.01; see figure 3). Sixty-three spots were successfully
matched to NCBI Blast database sequences and identified as listed in table 1. Of the 63
proteins, 30 increased in abundance, or showed an up-regulation in the differentiated cells
and 33 decreased in abundance, or were down regulated in the differentiated cells.

In general the proteins identified to increase after differentiation were functionally related
to cytoskeletal structure and dynamics, fatty acid synthesis, amino acid synthesis, protein
synthesis and glycolysis. Down regulated proteins were generally related to calcium
storage by the endoplasmic reticulum, mRNA processing in the nucleus, and the TCA
cycle within the mitochondria.

Table

1

represents

differentially

expressed

proteins

between

proliferating

(undifferentiated) MAC-T cells and differentiated MAC-T under DIP lactation media
conditions for 7 days. Identified proteins range in molecular weight from approximately
29 to 130 kDa, and in pI from 4 to 9. Proteins within the table are grouped based on
functional category and sorted within the group by protein name, direction of regulation
and fold change. Repetitions in protein names are associated with separate spots, which
may be explained by post-translational modifications or other differences that lead the
same protein to have either a different mass or pI.
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Figure 3. Fused Gel Image of MAC
MAC-T Protein Spots
Protein samples from proliferating and differentiated MAC
MAC-T
T cells were separated by
isoelectric point (horizontal axis) and molecular weight (vertical axis). Image represents a
fusion of all 12 gels (n=3 per treatment, in duplicate). Spots that differed in abundance
between treatments are circled and numbered. Numbers corres
correspond
pond with “Spot ID” in
table 1.

53

Figure 4. Heat Map of Significant MAC
MAC-T Proteins
Hierarchal clustering using Pearson’s correlation of MAC
MAC-T
T protein spots that changed
significantly between pregnancy and lactation states. Blue represents abundances lower
than the average for that particular spot, while orange represents greater than average
protein abundance. The columns represent individual gels clustered by treatment/cell
state. Rows represent
esent individual protein spot
spots.
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Table 1. Identified proteins that differed in abundance between proliferating and
differentiated MAC-T cells. “Regulation Direction” refers to change in protein spot
abundance from proliferating to differentiated cell state, which is quantified by “Fold
Change”. Fold change was calculated by dividing the mean spot abundance from
differentiated cell gels by the mean abundance of the same spot from proliferating cell
gels.
Spot
ID

Protein Name

152
151
45
102

Actin, Beta
Keratin 13-like
Keratin 6A
Keratin, (type II) Cytoskeletal
5

220

(Predicted) Vinculin Isoform
2
Ezrin
Gelsolin Isoform A
LIM and SH3 Domain Protein
1
Macrophage Capping Protein
Macrophage Capping Protein
Tripartite Motif-containing 29

13
207
125
114
98
24

124
209
133
215
196
104

198

122
90
31
181
182

119

187

Annexin A1
BiP (78kD Glucose-Regulated
Protein)
Calreticulin
Endoplasmin Precursor
Protein disulfide isomerase
Protein Disulfide-isomerase
A3 precursor

Heterogeneous Nuclear
Ribonucleoprotein U-like
Protein 2
Poly(rC)- Binding Protein 2
Pre-mRNA-processing Factor
19
Prelamin-A/C
Prelamin-A/C
Prelamin-A/C

6-Phosphogluconate
Dehydrogenase,
Decarboxylating

Elongation Factor 2

Fold
Change

Cytoskeletal Microfilaments
0.69
Actb
down
3.62
Krt13
up
2.28
Krt6A
up
0.58
Krt5
down

Gene
Name

Regulation
Direction

P-value

MW
(kDa)
Predicted

pI
Predicted

0.003
<0.001
<0.001
0.001

41679.72
47183.24
60782.58
62449.11

5.29
4.86
8.28
6.90

116642.35

5.83

68717.49
85634.23
29658.13

6.06
5.86
6.61

Cytoskeletal Dynamics
Vin2
up

1.97

Ezr
Gsna
Lasp1

up
up
up

1.87
2.93
1.57

<0.001
0.003

up
up
down

1.93
1.60
0.72

<0.001
0.001
0.004

38851.79
38851.79
64931.20

6.17
6.17
6.70

Calcium Trafficking/Storage
1.76
Anxa1
up
0.72
Grp78
down

<0.001
<0.001

38927.26
62978.81

6.37
5.31

48067.88
92369.23
57167.77
56893.91

4.33
4.76
4.80
6.38

Capg
Capg
Trim29

0.001

0.002

down
down
down
down

0.54
0.53
0.55
0.55

0.001
<0.001
<0.001

Nuclear Proteins
Hnrnpul2
down

0.50

<0.001

85139.05

4.84

Pcbp2
Prpf19

up
down

2.21
0.47

<0.001
<0.001

36777.74
55160.36

6.60
6.14

Lmna
Lmna
Lmna

down
down
down

0.38
0.58
0.70

0.001
0.001
0.001

65082.57
65082.57
65082.57

6.54
6.54
6.54

53042.87

6.65

95306.96

6.41

Calr
Hsp90B1
P4hb
Pdia3

0.001

Pentose Phosphate Pathway
3.45
Pgd
up
0.001

Eef2

Protein Synthesis
up
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4.23

<0.001

183
109
14
199
135

121
61
38
166
50
53

117

127
108
95
107
71
69
39

48

169
28

179

115
140
141
168
25

51
78
185
81

Elongation Factor 2
Elongation Factor Tu,
mitochondrial precursor
Glycyl-tRNA Synthetase
Hypoxia up-regulated protein
1
Chaperonin (HSPD1 Protein)

Argininosuccinate Synthase
Argininosuccinate Synthase
Bifunctional Purine
Biosynthesis Protein (PURH)
GMP Synthase
Glutamate Dehydrogenase 1
Serine
Hydroxymethyltransferase,
mitochondrial precursor
Serine
Hydroxymethyltransferase,
mitochondrial precursor

Alpha-Enolase
Alpha-Enolase
Alpha-Enolase
Alpha-Enolase
Glyceraldehyde-3-Phosphate
Dehydrogenase
Glyceraldehyde-3-Phosphate
Dehydrogenase
Phosphoglucomutase-1

up
up

2.41
1.55

<0.001

Gars
Hyou1

up
down

1.92
0.60

Hspd1

down

Eef2
Eef2

95306.96
49367.01

6.41
6.72

<0.001
<0.001

83064.51
111543.35

6.94
5.26

0.50

<0.001

42137.67

8.90

Amino Acid Synthesis/Metabolism
1.71
Ass1
up
1.35
Ass1
up
1.79
Atic
up

<0.001
0.006
<0.001

46387.85
46387.85
64442.22

7.15
7.15
6.39

<0.001
<0.001

77271.31
57630.23
55570.39

6.44
7.04
7.62

55570.39

7.62

47254.35
47254.35
47254.35
47254.35
35845.30

6.37
6.37
6.37
6.37
8.51

35845.30

8.51

61550.75

6.36

54153.06

7.59

78501.72
70604.72

6.67
8.14

70604.72

8.14

56315.10

6.71

129728.71
129728.71
61388.73
60804.94

6.32
6.32
8.62
6.19

51169.38

7.16

35068.57

7.60

86019.27
35313.77

6.27
6.97

Gmps
Glud1
Shm1

down
down
down

0.29
0.45
0.47

0.005

0.006
Shm1

down

0.70
0.004

Eno1
Eno1
Eno1
Eno1
Gapdh

Glycolysis
up
up
up
up
up

3.26
3.25
2.06
1.91
2.36

Gapdh

up

1.51

Pgm1

up

3.04

<0.001
<0.001
<0.001
<0.001
0.001
0.005
0.001

TCA Cycle/Mitochondrial Energy Metabolism
0.52
Dld
down
Dihydrolipoyl
Dehydrogenase,
0.001
mitochondrial
0.60
Mitochondrial Aconitase 2
Aco2
down
0.002
0.52
<0.001
Pck1
down
Phosphoenolpyruvate
Carboxykinase (GTP),
mitochondrial
0.62
<0.001
Phosphoenolpyruvate
Pck1
down
Carboxykinase (GTP),
mitochondrial
1.51
Phosphoglycerate
Phgdh
up
0.004
Dehydrogenase
0.13
<0.001
Pyruvate Carboxylase
Pc
down
0.38
<0.001
Pyruvate Carboxylase
Pc
down
1.81
<0.001
Pyruvate Kinase Isozyme M2
Pkm2
up
0.57
<0.001
Succinate Dehydrogenase
Sdha
down
(complex subunit A)

Adenylate cylase-assosiated
protein 1
Guanine nucleotide-binding
protein subunit beta-2-like 1
Phosphlipase C-delta 1
YWHAZ Protein (Homo

Cap1

Cell Signaling
down

0.72

down

0.66

up
up

1.80
3.43

Gnb2l1
Plcd1
YWHAZ
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0.004
0.001
<0.001
0.009

sapien)

94

Rab GDP Dissociation
Inhibitor Beta

224
153
77

(Predicted) Integrin Alpha-3
40S Ribosomal Protein SA
Voltage-Dependent AnionSelective Channel Protein 2

218
217

Albumin (ALB)
Albumin (ALB)

Gdi2

GTP Synthesis
up

1.74

Cell Surface/Membrane Proteins
0.33
Itga3
down
0.40
Rpsa
down
0.49
Vdac2
down

Alb
Alb

Serum Protein
down
down

0.34
0.35

0.002

<0.001
0.001
0.001

0.003
0.002

50455.67

5.93

95515.79
32876.44
31599.56

6.35
4.80
7.47

69190.43
69190.43

5.88
5.88

* Molecular weight (MW) and pI values estimated by ExPASy – Bioinformatics Resource Portal (www.expasy.org)
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2.4 Discussion

This study was designed to compare global protein expression in MAC-T cells before and
after in vitro differentiation. Our interest in this transition within the MAC-T cell line
arose due to results from an earlier experiment, which compared the proteomes of MACT cells that had been differentiated in vitro and treated with or without exogenous growth
hormone. Many of the proteins observed to change with GH treatment have known
functions that may be associated with the transition to differentiation or establishment of
lactogenesis in the mammary gland. The intent in designing the current study was to
compare the stages of proliferation and differentiated MAC-T cells in order to then
compare these results with those from the GH study. This discussion will address the
changes in the proteome we observed in the current study and assess similarities between
the current study and the GH treatment experiment previously conducted by Johnson et
al.

The majority of metabolic proteins that we observed to differ in abundance were related
to the glycolytic pathway, TCA cycle and NADPH production, which is what we would
expect from a bovine mammary epithelial cell preparing for lactose and fatty acid
synthesis. We also observed changes in proteins related to cytoskeletal dynamics and
RNA processing which was also expected due to the structural changes that must occur in
order for lactation to proceed.
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Calcium Storage/Trafficking Proteins
Specifically related to the endoplasmic reticulum (ER), we observed down-regulation of
ER resident proteins: calreticulin, endoplasmin (precursor), BiP (precursor; also known
as 78kD glucose regulated protein) and two forms of protein disulfide-isomerase (P4hb
and Pdia3). Calcium, commonly associated with the health benefits of milk is also
necessary for a number of functions throughout the cytoplasm of all cells. Calcium is
stored in the ER and must be transported throughout the cell via “chaperones” in order to
perform its functions. While all of the ER proteins we detected have calcium binding
capabilities, calreticulin has the highest capacity and with a phosphorylation site for
casein kinase II may have a role in the secretion of calcium in milk (Rowling, 1994).

The fact that we saw a decrease in abundance of these ER proteins after differentiation
may illustrate a decreased need for the intracellular distribution of calcium for functional
processes related to proliferation and perhaps a faster turnover between calcium influx
and output through casein secretion. If this were the case, there may be a decrease in the
need for ER storage and chaperoning of calcium by ER proteins. This hypothesis is
supported by the up regulation of the protein annexin 1. Annexin 1 binds phospholipid, of
which the cell membrane is made, but only when also bound to calcium, leading to a
possible connection between annexin 1 and the exocytosis of secretory vesicles
containing milk components (Creutz, 1992).
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Metabolic Proteins
In the ruminant mammary gland glucose availability is limited, and lactose synthesis is
generally believed to be the first priority of glucose use. Consistent with this theory, we
saw an up-regulation in phosphoglucomutase which is an enzyme involved in lactose
synthesis. We also observed changes in other proteins related to glucose use including
up-regulation of several glycolytic enzymes, including glyceraldehyde-3-phosphate
dehydrogenase, alpha-enolase and phosphoglycerate dehydrogenase. The increase in
abundance of these proteins indicates an increase in glucose breakdown to pyruvate,
probably related to the increased energy demands during milk synthesis. However, the
fate of the increased pyruvate stores that this pathway would generate is debatable.

Within the mitochondrial TCA cycle, we observed a down-regulation in both
dihydrolipoyl dehydrogenase and pyruvate carboxylase which are the two mitochondrial
catalysts for reactions in which pyruvate is a substrate. Phosphenolpyruvate
carboxykinase (PEPCK), which is the enzyme that can reversibly convert oxaloacetate to
phosphoenolpyruvate (PEP), was also down regulated. However, pyruvate kinase was up
regulated and this is the enzyme completing the final and irreversible transition of PEP to
pyruvate. The changes in the above metabolic proteins appear to indicate a build up of
pyruvate though glycolysis and conversion of PEP to pyruvate as well as an inhibition of
the TCA cycle. Under aerobic conditions, if the fate of pyruvate is not the production of
ATP through the TCA cycle, it may be participating in a transamination reaction in the
presence of glutamate to produce both alpha-ketoglutarate and alanine. Alanine is a nonessential amino acid (NEAA) that may be required to produce new proteins, and alpha-
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ketoglutarate can contribute to other pathways. For example, mitochondrial aconitase was
down regulated, and this enzyme is responsible for another conversion within the TCA
cycle involving the reversible transition of citrate to isocitrate. Alpha-ketoglutarate can
also be converted to isocitrate in the mitochondria, and isocitrate can be shuttled out of
the mitochondria to the cytosol and used as a precursor to NADPH production. If there is
an abundance of isocitrate in the mitochondria as a result of transamination of pyruvate, it
would reduce the need to convert citrate to isocitrate, sparing the energy that reaction
would cost. NADPH is the required reducing agent for fatty acid synthesis, and the
majority of it is most likely produced by this particular reaction in the ruminant due to
absence of citrate lyase activity and limited availability of glucose for the pentose
phosphate pathway. Even though it is most likely secondary to isocitrate dehydrogenase
production, the pentose phosphate pathway remains a source of NADPH production, and
this is supported by our data through the observed increase in abundance of 6phosphogluconate dehydrogenase (for reference, see figures 1 and 2 in chapter 1).

Cytoskeletal Proteins and Cytoskeletal Dynamics-related Proteins
As epithelial cells differentiate they change in structure, shape and motility and changes
in cytoskeletal proteins related to these transformations were to be expected. The cellular
cytoskeleton is made up of microfilaments assembled from actins, intermediate filaments
and microtubules. Among cytoskeletal proteins detected to change, we saw an up
regulation in keratins 6a and 13, which are both typical intermediate filaments in
epithelial cells. Specifically keratin 6a is expressed only in luminal epithelial cells and
cells of terminal end buds within the mammary ductal system, a fact that supports our
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selection of MAC-T as a model for this cell type (Bu, 2011). Additionally, we observed a
down regulation of keratin 5, and this is a filament expressed during the differentiation of
epithelial cells and is perhaps no longer necessary to a fully differentiated, lactating
phenotype.

Beta-actin was the only actin sub-unit in which we detected a change and it was down
regulated. This does not necessarily contradict the up regulation of keratins because reorganization is bound to change demands for different building materials in the
cytoskeleton. Specifically, actin is often associated with cell motility, an important
characteristic for epithelial cells during proliferation in order to populate a mammary
gland (Mayanagi, 2011). However, once the functional epithelium is established and
differentiated to a lactating phenotype, motility is no longer necessary and would likely
hinder milk secretion. Complementary to this analysis, we saw up regulation of proteins
related to cytoskeletal dynamics and actin re-organization such as gelsolin-a, LIM and
SH3 domain protein 1 and macrophage capping protein, which indicate a change in cell
structure that may have altered the activity of actin post-translation. LIM and SH3
domain protein 1 has been identified in other secretory epithelial cell types as well, and is
thought to be involved in linking intracellular signaling pathways, including, but not
limited to, regulating actin-related ion transport (Chew, 2000).

Gelsolin is an actin-capping and severing protein, meaning it binds to actin filaments to
prevent the exchange of monomers with the unique ability to both assemble or sever
formed filaments. Gelsolin is decreased in breast tumors, and up-regulate in response to
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anti-growth medication indicating a preventative effect on motility and proliferation
(Brackley, 2011). Macrophage capping protein is alternately known as “gelsolin-like
capping protein” and shares many characteristics with gelsolin in relation to actin-based
cell motility although it was originally isolated from alveolar macropahges (Zhu, 2011).
Interestingly, macrophage capping protein was also up-regulated in response to GH
treatment in the previously conducted MAC-T experiment.

In relation to cytoskeletal dynamics, we saw an increase in the abundance of proteins
viniculin 2 and ezrin which both function as intermediates connecting the plasma
membrane of the cell to the cytoskeleton. Viniculin binds actin filaments and is involved
in cell-to-cell and cell matrix adhesion (Coll, 1995). Ezrin has been associated
specifically with the apical membrane and the maintenance of polarity in epithelial cells.
Adhesion for signaling and established polarity are essential characteristics for lactation
in the epithelium (Saotome, 2004).

Lamin A/C are also cytoskeletal proteins, but are more closely related to the nucleus.
These intermediate filament proteins, present in all mammals, comprise the inner most
layer of the nuclear membrane termed nuclear lamina. Recently, it has been proposed that
lamins are not only structural in nature, but also interact with chromatin affecting gene
regulation (Puckelwartz, 2011). Lamin-associated domains have been identified which
allow chromatin to interact directly with the nuclear lamin, causing a change in
transcription, which is most often a repressive effect (Puckelwartz, 2011). If
differentiation does in fact reduce the abundance of nuclear lamins, and therefore reduces
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the interaction between lamins and repressive lamin-associated domains, this effect may
contribute to a change in genes being transcribed for the new, functional cell state.

Proteins of Particular Interest
One unexpected change was observed in YWHAZ protein, one of the most significantly
up-regulated proteins observed. YWHAZ is known to be involved in the regulation of a
spectrum of general cell signaling pathways. Its increase of greater than 3 fold between
states of differentiation is interesting due to the fact that the gene for this protein has been
previously been deemed appropriate as a “housekeeper” or reference gene for PCR
studies in 33 bovine tissues including the mammary gland (Lecchi, 2012). This provides
an excellent example of discrepancy between mRNA and protein abundance. While it
may be a good reference gene on the transcript level, the abundance of this protein may
not be dictated by the abundance of mRNA.

Another unexpected result was the up-regulation of argininosuccinate synthase, which we
observed in differentiated MAC-T. Argininosuccinate synthase is an enzyme generally
associated with the urea cycle that is not typically associated with the mammary gland. In
fact until very recently, this enzyme has been linked exclusively to the liver. In a review
published in 2011, it was noted that argininosuccinate synthase plays a role not only in
the urea cycle, but also in several other pathways including de novo arginine synthesis
(Haines, 2011). Arginine is often considered a “semi-essential” amino acid, due to the
fact that most adult animals produce enough arginine in the kidneys to balance dietary
sources, reaching the required metabolic demand (Haines, 2011). In the neonate however,
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enterocytes also express argininosuccinate synthase perhaps due to the fact that milk is
relatively low in arginine when compared to the needs of growing young. The uptake of
arginine from the plasma by the lactating mammary gland of the sow has been
demonstrated to be significantly lower than the output of arginine in milk, indicating a
demand for arginine in the process of lactation (O’Quinn, 2002). It is feasible then, that
de novo arginine synthesis is occurring within the lactating MEC in order to meet this
demand. Specific fates of this amino acid warrant further investigation.

Relationship with Growth Hormone Experiment
In the previously conducted study comparing differentiated MAC-T cells treated with and
without GH, analysis suggested a possible parallel between the transition of
differentiation and the direct effect of GH on the mammary epithelial cell. When
comparing results from the two experiments, there is a great deal of overlap in the
functional groups of proteins that changed in abundance, and several of the same proteins
changed in the same direction of regulation. Notably, the up regulation observed in
pathways promoting and increase in NADPH production are similar to those seen with
GH treatment. As discussed, NADPH is an important factor in fatty acid synthesis, which
is essential to milk production, especially in the ruminant. Also similar was the increase
in glycolytic enzyme, alpha-enolase, which facilitates the last step in glycolysis resulting
in the production of phosphoenolpyruvate from 2-phosphoglycerate. This increase may
indicate an increase in the use of glycerol from TAG for the synthesis of pyruvate, which,
as previously discussed, may be contributing to NEAA synthesis through transamination.
By taking advantage of glycerol in this manner, glucose may be spared for lactose
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synthesis without detriment to the TCA cycle and associated pathways in the ruminant
cell.

Additionally, there were similarities in the changes of cytoskeletal proteins indicating a
similar re-organization of the cell structure due to functional differentiation of the cell
and treatment with GH. The hypothesis postulating an overlap between the effect of GH
and the changes that occur between the proliferation of mammary epithelium and the
stage of functional differentiation is supported in part by these similarities, providing
additional evidence that the effect of GH on the mammary epithelium may be to
potentiate the process of differentiation. Future experiments could be designed based on
this hypothesis with more specificity to individual genes, proteins and pathways. A time
course experiment would also be beneficial to observe how changes occur through the
process of differentiation as opposed to just looking at singular time-points before and
after this functional shift in the mammary epithelium.

As we have demonstrated, immortalized cell lines are excellent sources upon which
hypotheses may be based. These cells are homogenous, easy to obtain and undergo
structural and functional changes in vitro that qualify as induced differentiation.
However, it is important to consider the probable effects of human intervention and the
unnatural, in vitro environment. The following chapter will describe an experiment
designed to compare what we observed in the MAC-T cell line with primary cells
isolated before and after in vivo differentiation, in order to test and improve our
hypotheses.
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CHAPTER 3 – A proteomic analysis of differentiation, in vivo through the comparison
primary mammary epithelial cells from pregnant and lactating mice

3.1 Introduction

Although rudimentary development of the mammary gland begins during fetal
development and puberty, a mammary gland does not fulfill its functional potential until
the female has undergone a full-term pregnancy and parturition (Gjorevski, 2011). The
mammary gland undergoes major development during pregnancy, characterized by the
tertiary side-branching of the ductal structure and the exponential proliferation of
epithelial cells, some of which will undergo a final differentiation to become secretory,
milk-producing cells (Brisken, 2006). In the context of protein biosynthesis, this
transition begins with the up-regulation of enzymes involved in the synthesis of milk
components, specifically lactose, caseins, and whey proteins alpha-lactalbumin and betalactoglobulin. Although the hormonal signals prompting this switch in cellular function
of the mammary epithelium have long been understood, the molecular events within the
epithelial cell, which physically establish the new phenotype, are still somewhat unclear
(Gjorevski, 2011).

In this study, primary mammary epithelial cells (pMEC) were isolated from whole
mammary glands of ICR mice at mid-pregnancy or peak lactation. Total protein was
extracted from each cell type and global protein expression was visualized by twodimensional gel electrophoresis (2DE) before identification of individual proteins that
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changed significantly in abundance through MALDI-TOF/TOF mass spectrometry for
analysis.
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3.2 Methods

All reagents were purchased from Sigma Aldrich (St. Louis, MO) unless otherwise noted.
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3.2.1 Animals

ICR mice were purchased from Taconic Farms, Inc. (Oxnard, CA). All protocols were
designed in accordance with the PHS Policy for Humane Care and use of Laboratory
Animals and approved by the California Polytechnic State University Institutional
Animal Care and Use Committee.
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3.2.2 Primary Cell Isolation

Fat pads were excised from 7-10 week-old ICR outbred mice at either day 10 of
pregnancy or day 10 of lactation and rinsed in 1X Hank’s Balanced Salt Solution
(HBSS). Tissue was manually minced to fragments of approximately 3mm3 and digested
in a collagenase, trypsin, EDTA and Dulbecco’s Modified Eagle’s Medium (DMEM)
cocktail during a 90-minute shaking incubation at 37°C. The cell pellet was sequentially
re-suspended and incubated in red blood cell (RBC) lysis buffer (Millipore, MA), EDTA
and DNase solutions before filtration through a 100um filter. As fibroblasts (a
contaminating cell type) adhere very quickly to plastic, they were removed through a
one-hour incubation on a T-182 flask. Epithelial cells that remained in suspension after
one hour were removed, centrifuged and re-suspended in a 1x DMSO cell freezing
medium and brought to -80°C over night. Frozen vials were stored in liquid nitrogen until
the date of protein extraction.
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3.2.3 Protein Isolation, 2DE, Tryptic Digestion and MALDI TOF/TOF Mass
Spectrometry and Data Analysis

All protein samples were isolated, treated and analyzed as described in chapter 2, sections
2.2.2-2.2.5.
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3.2.4 Flow Cytometry

Viability of primary cells was determined through the use of ViaCount (Guava/Millipore)
and its associated computer application in conjunction with a Millipore flow cytometer.
Cell pellets from each vial were collected by centrifugation at 400 x g for 5 minutes. Cell
freezing media was removed and pellets were rinsed in phosphate buffered saline solution
(PBS) twice. Two aliquots of each cell type were taken at this point for cell viability
estimation. Trypan blue (Thermo Scientific, South Logan, UT) was added to the first
aliquot of each cell type for visual examination of viability on a hemocytometer (Hausser
Scientific, Horsham, PA). This visual estimation was compared with flow cytometry after
the second aliquot was incubated with ViaCount solution according to the product
literature and suggested protocols.
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3.3 Results

Flow cytometry determined cells isolated from pregnant mice to be 40% viable and cells
from lactating mice to be 41% viable immediately after thaw from liquid nitrogen.
Unfortunately, our efforts to validate the epithelial origin of the primary cells were
inconclusive (please see appendix).

Through the use of Delta2D, 125 spots on the composite image of all gels were identified
to be significantly different between the two treatment groups (p < 0.01). A total of 92
spots were successfully matched to NCBI Blast database sequences to be identified as
specific proteins listed in table 2. Of the 92 proteins identified to change, 45 proteins
were up regulated and 47 were down regulated in mammary epithelial cells from
lactating mice compared to pregnant. Overall, 18 proteins matched proteins listed in table
1 in the previous chapter, although the direction of regulation was the same for only 7 of
those 18; the remaining similar proteins were regulated in the opposite direction.
Although this overlap in specific proteins may seem insubstantial, the functional groups
into which changing proteins were divided show great similarity.

In general, the proteins that increased in abundance from pregnancy to lactation were
functionally related to fatty acid synthesis, amino acid catabolism, tricarboxylic acid
cycle and electron transport chain, and secreted proteins. The down-regulated proteins
were generally related to cytoskeletal structure and dynamics, protein synthesis, mRNA
processing and transcription, and molecular chaperoning.
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Table 2 represents differentially expressed proteins between proliferating cells isolated
from the developing mammary gland of a mid-pregnant ICR mouse and differentiated
cells isolated from a lactating ICR mouse. Identified proteins range in molecular weight
from approximately 23 to 272 kDa, and in pI from 4 to 11. Proteins within the table are
grouped based on functional category and sorted within the group by protein name,
direction of regulation and fold change. Repetitions in protein names are associated with
separate spots, which may be explained by post-translational modifications or other
differences that lead the same protein to have either a different mass or pI.
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Figure 5. Fused Gel Image of Primary Murine Mammary Epithelial Cell Protein Spots
Protein samples from the mammary epithelial cells isolated from pregnant and lactating
mice were separated by isoelectric point (horizontal axis) and molecular weight (vertical
axis). Image represents a fusion of all 12 gels (n=3 per treatment, in duplicate).
duplicate) Spots that
differed in abundance bet
between treatments are numbered. Numbers correspond with “Spot
ID” in table 2.
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Figure 6. Heat Map of Significant Primary
Prim
Murine Mammary Epithelial Cell Proteins

Hierarchal clustering using Pearson’s
correlation of murine mammary epithelial
cell protein spots that changed significantly
between pregnancy and lactation states. Blue
represents abundances lower than the
average
erage for that particular spot, while orange
represents greater than average protein
abundance.
The
columns
represent
individual gels clustered by treatment/cell
state. Rows represent individual protein
spots.
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Table 2. Identified proteins that differed in abundance between mammary epithelial cells
isolated from pregnant and lactating mice. “Regulation Direction” refers to the change in
protein spot abundance from pregnant to lactating cell stages, which is quantified by
“Fold Change”. Fold change was calculated by dividing the mean spot abundance from
lactating mouse gels by the mean abundance of the same spot from pregnant mouse gels.

Spot
ID

97
57
136
123
124
72

64
63
67
117

18

Protein Name

Keratin 18
Keratin 5
Keratin 8
Keratin 8
Keratin 8
Vimentin

Elfin
LIM and SH3 Domain
Protein 1
Macrophage Capping
Protein, isoform 2
Protein Disulfide-Isomerase
(precursor)

Gene
Name

Regulation
Direction

Fold
Change

Pvalue

MW (Da)
Predicted

pI
Predicted

Cytoskeletal Microfilaments
Krt18
down
Krt5
up
Krt8
down
Krt8
down
Krt8
down
Vim
down

0.41
2.34
0.34
0.45
0.53
0.40

0.003
<0.001
<0.001
0.002
0.006
0.003

47460.24
61742.60
54531.46
54513.50
54531.46
51533.09

5.3
7.6
5.7
5.7
5.7
5.0

Cytoskeletal Dynamics
Pdlim1
down
LASP1
down

0.29
0.29

0.006
0.003

35751.89
29975.31

6.4
6.6

CAPG

down

0.25

0.002

38744.68

6.5

up

2.80

<0.001

57022.77

4.8

0.40

0.002

46644.47

6.7

up

1.95

0.002

33637.62

7.7

down

0.54

0.001

67587.58

7.2

2.01

<0.001

46407.57

8.6

P4hb

NADPH Production
down

Isocitrate Dehydrogenase,
cytoplasmic
Pyrroline-5-carboxylate
reductase 2
Transketolase

Idh1

Acyl-coenzyme A
Dehydrogenase, medium
chain
Fatty Acid Synthase
Monoglyceride Lipase
(isoform a)

Acadm
Fasn
Mgll

up
up

5.46
3.45

<0.001
<0.001

272256.77
35233.96

6.1
7.2

144
143
91
127

Elongation Factor 2
Elongation Factor 2
Elongation Factor 2
Serine, tRNA ligase

Eef2
Eef2
Eef2
Sars

Protein Synthesis
down
down
down
down

0.46
0.50
0.58
0.43

0.005
0.009
<0.001
<0.001

95252.89
95252.89
95252.89
58720.97

6.4
6.4
6.4
6.2

111

Bifunctional Purine
Biosynthesis Protein
(PURH)
Inosine-5'-monophosphate
Dehydrogenase 2
Serine
Hydroxymethyltransferase

Atic

Amino Acid Metabolism
down

0.33

<0.001

64177.42

6.5

up

1.87

<0.001

55779.77

6.3

down

0.36

<0.001

52551.50

6.5

81
4

21
87
33

7
65

Pycr2
Tkt

Fatty Acid Synthesis
up

Impdh2
Shmt2

78

86
82

60

96
36
37
8
109
145
41
42
40
19
12
110
140
139
20
103
121
9

13

58
32
105
50

3-hydroxyisobutyrate
dehydrogenase,
mitochondrial precursor
Acetyl-CoA
acetyltransferase,
mitochondrial

Hibadh

up

1.51

0.006

35416.60

8.4

Acat1

up

1.45

0.005

44787.34

8.7

Alpha-Enolase

Eno1

Glycolysis
down

0.58

0.004

47098.24

6.2

Mitchondrial Matrix/TCA Cycle
Aco2
up
2.30
Aco2
up
1.59
Aco2
up
1.42
Aldh2
up
2.02
Aldh4a1
up
2.02
Ogdh
down
0.30

<0.001
0.01
0.002
0.002
<0.001
0.005

85444.00
85444.00
85444.00
57924.49
39448.25
117683.21

8.1
8.1
8.1
8.3
7.8
6.5

CS

up

6.13

<0.001

51703.38

8.7

Cs

up

3.48

<0.001

51703.38

8.7

Cs

up

2.37

0.001

51703.38

8.7

Cs

up

1.84

<0.001

51703.38

8.7

Glud1

up

1.43

0.004

61298.17

8.1

down

0.35

<0.001

70448.40

6.9

Pc

up

5.10

<0.001

129602.46

6.3

Pc

up

3.78

0.001

129749.50

6.3

Pdha1

up

1.98

<0.001

43203.63

8.5

PDHB

up

5.99

<0.001

34813.76

5.6

Dlat
Oxct1

up
up

2.22
2.30

<0.001
<0.001

67898.68
55953.00

8.8
8.7

Oxct1

up

2.22

<0.001

55953.00

8.7

27605.98

8.3

35017.51

8.6

79265.35

7.7

72539.17

7.1

Aconitase 2, mitochondrial
Aconitase 2, mitochondrial
Aconitase 2, mitochondrial
Aldehyde Dehydrogenase
Aldehyde Dehydrogenase
Alpha-ketoglutarate
Dehydrogenase
Citrate Synthase,
mitochondrial precursor
Citrate Synthase,
mitochondrial precursor
Citrate Synthase,
mitochondrial precursor
Citrate Synthase,
mitochondrial precursor
Glutamate Dehydrogenase 1,
mitochondrial
Phosphoenolpyruvate
Carboxykinase 2,
mitochondrial
Pyruvate Carboxylase,
mitochondrial
Pyruvate Carboxylase,
mitochondrial
Pyruvate Dehydrogenase E1
(subunit alpha),
mitochondrial
Pyruvate Dehydrogenase E1
(subunit beta), mitochondrial
Pyruvate Dehydrogenase E2
Succinyl-CoA: 3-ketoacidcoenzyme A transferase 1,
mitochondrial precursor
Succinyl-CoA: 3-ketoacidcoenzyme A transferase 1,
mitochondrial precursor

Pck2

Inner Mitochondrial Membrane/Electron Transport Chain
Electron Transfer
Etfb
up
2.16 <0.001
Flavoprotein (subunit beta)
Electron Transferring
Etfa
up
2.12 <0.001
Flavoprotein, alpha
polypeptide
Methylcrotonyl-coenzyme A Mcca
down
0.42 <0.001
Carboxyl (alpha)
Succinate Dehydrogenase
Sdha
down
0.53 <0.001
Flavoprotein (subunit a),
mitochondrial precursor

79

48
39

30
59
101
54
105
56
66

3
94
75
76
61

83
79

ATP Synthase (subunit
alpha), mitochondrial
ATP Synthase (subunit
alpha), mitochondrial

Atp5a1

up

2.81

0.002

59715.59

9.2

Atp5a1

up

1.48

<0.001

59715.59

9.2

Arginine/Serine-rich
Splicing Factor 1
Arginine/Serine-rich
Splicing Factor 2
Nucleophosmin 1
Pre-mRNA Processing
Factor 19 (isoform 2)
Prelamin A/C
Prelamin A/C
Proliferation Associated
Protein 2G4

Srsf1

Nuclear Proteins
down

0.35

<0.001

24421.16

10.1

Srsf2

down

0.38

<0.001

25461.18

11.9

Npm1
Prpf19

down
down

0.25
0.60

<0.001
0.009

32567.84
55204.39

4.6
6.1

Lmna
Lmna
Pa2g4

down
down
down

0.42
0.52
0.38

<0.001
0.008
0.002

65406.68
65406.68
43671.21

6.4
6.4
6.4

Far-upstream Element
Binding Protein 1
Far-upstream Element
Binding Protein 2
KappaB Motif binding
phosphoprotein
KappaB Motif binding
phosphoprotein
TAR DNA-binding Protein
43 (isoform 1)

Fubp1

0.35

0.004

44933.88

9.0

Heterogenous Nuclear
Ribonucleoprotein A3
Heterogenous Nuclear
Ribonucleoprotein A3-like
Heterogenous Nuclear
Ribonucleoprotein H
Heterogenous Nuclear
Ribonucleoproteins A2/B1
Heterogenous Nuclear
Ribonucleoproteins C1/C2
Heterogenous Nuclear
Ribonucleoproteins C1/C2
Heterogenous Nuclear
Ribonucleoproteins C1/C2

Transcription Factors
down

Fubp2

down

0.64

0.001

79348.69

9.0

Hivep3

down

0.27

<0.001

51010.40

5.2

Hivep3

down

0.35

0.002

51010.40

5.2

Tdp43

down

0.61

<0.001

44519.29

6.3

mRNA Processing/Transport
Hnrnpa3
down
0.18

0.001

37063.20

8.5

Hnrnpa3

down

0.15

<0.001

23529.62

7.1

Hnrnph1

down

0.40

<0.001

49168.40

5.9

Hnrnpa2b1

down

0.28

0.001

32440.44

8.7

Hnrpc

down

0.12

<0.001

34363.86

4.9

Hnrpc

down

0.21

<0.001

34363.86

4.9

Hnrpc

down

0.40

0.002

34363.86

4.9

TNF Receptor-Associated
Protein 1

Traf1

Cell Signaling
up

1.61

0.002

81155.13

6.4

34

G-protein (beta subunit-like)

Gnb1

GTP Synthesis
up

1.56

<0.001

34996.55

8.1

47

T-complex Protein 1
(subunit beta)
Valosin-Containing Protein
Valosin-Containing Protein

Cct2

Molecular Chaperones
down

0.33

<0.001

59614.11

8.0

0.41
0.48

0.002
<0.001

89251.70
89251.70

5.1
5.1

135
80
100
99
98

118

69
70

Nvl
Nvl

down
down

80

35
90

Homeostatic Maintenance
down
up

Carbonic Anhydrase 2
Mercaptopyruvate
Sulfurtransferase
Sialic Acid Synthase

Ca2
Mpst

49
78

EH-domain Containing 4
Voltage-Dependent AnionSelective Channel Protein 2

Ehd4
Vdac2

102
1

95
114
115
2
128
116

Alpha-s1 Casein
Hemiferrin, Transferrin-like
Protein
Serotransferrin precursor
(bos taurus)
Transferrin
Transferrin
Transferrin
Transferrin
Transferrin
Transferrin

120
119

Albumin
Albumin

27

130

84

ES1 Protein homolog,
mitochondrial precursor

0.10
1.58

<0.001
<0.001

29014.50
33018.53

6.5
6.1

0.39

0.002

39998.36

6.6

0.48
1.61

0.002
<0.001

61453.32
31712.58

6.1
7.4

Secreted Proteins
Csn1
up
LOC286987
up

4.05
1.64

0.001
<0.001

34775.43
24075.49

6.3
7.9

TF

up

4.54

<0.001

77615.72

7.1

Trf
Trf
Trf
Trf
Trf
Trf

down
up
up
up
up
up

0.64
6.72
6.21
3.08
3.06
2.91

<0.001
<0.001
<0.001
<0.001
0.003
<0.001

76627.67
76627.67
76627.67
76627.67
76627.67
76627.67

6.9
6.9
6.9
6.9
6.9
6.9

Alb
Alb

Serum Protein
up
up

3.46
2.82

0.001
<0.001

68647.71
68264.81

5.8
5.9

3.14

0.007

28072.78

9.0

Nans

down
Membrane Proteins
down
up

Unknown Function
D10Jhu81e
up

*values estimated by ExPASy – Bioinformatics Resource Portal (www.expasy.org)
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3.4 Discussion

In this chapter, we have presented a comparison of proteomic expression by the
mammary epithelial cell during mid-pregnancy and peak lactation in the ICR mouse. The
total gestation period for this breed of mouse is approximately 19 days. Day 10 of
pregnancy was selected as the first day of cell isolation due not only to it being a halfway-point in gestation, but also due to previous studies showing day 10 as a point at
which proliferation of the epithelium was still occurring yet alveoli had not yet begun to
develop (Brisken, 2006). Day thirteen of lactation has been demonstrated to be the point
of “peak lactation” in former mouse studies, so we selected day 10 post-parturition as our
second isolation point, assuming the mammary gland would be fully differentiated to a
lactating state and not yet transitioning into apoptosis or regression (Brisken, 2006).

Because our focus in this study is specific to the mammary epithelium, it was necessary
to isolate only this cell type from the surrounding mammary gland. While plating and
culturing the primary cells would have benefitted our sample volume and reduced
contamination of dead cells and debris, our goal was to measure the proteins being
expressed at these specific stages in vivo, and so we chose not to plate or culture the cells
prior to protein extraction. The mammary epithelial layer, as it exists within the
mammary gland, is spherical within alveoli and tight junctions are formed between cells.
In order for individually isolated primary cells to attach to a flat, plastic surface such as a
culture dish, it is very likely they must undergo significant proteomic changes to adapt to
that new environment. Furthermore, if cells isolated from an animal during established
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lactation are encouraged to revert to a proliferative state in vitro, they cannot be assumed
to express a proteome representative of a lactating mammary gland. A change in
translation occurs over many hours and we cryogenically froze primary cells immediately
after isolation. We decided that extracting protein samples from cells immediately postthaw would then be the best strategy for obtaining the most accurate representation of in
vivo proteomic expression in the mammary epithelium.

As attempts to successfully validate the epithelial nature of our primary cells were
unsuccessful, it is necessary to discuss the possible contaminating cell types in the sample
population. The mammary epithelium exists within a fat pad in the mouse, which
contains a great deal of adipose tissue and stroma. Adjacent to the epithelium are
myoepithelial cells, the extracellular matrix, made up of fibroblasts, and blood vessels.
Due to the extremely adherent properties of fibroblasts, they are likely removed from the
epithelial population though a one-hour incubation period on a plastic surface during the
cell isolation procedure. Adipose cells are removed through centrifugation, as this cell
type is less massive than others and forms a layer above liquids used during the cell
isolation procedure. Other stroma and blood should be absent from the sample due to
collagenase and red blood cell lysis buffers also employed during the primary cell
isolation process.

The majority of differences in global protein expression in mammary epithelial cells
isolated from pregnant and lactating mice appear to be related to metabolism, structure
and RNA processing. These proteins, and probably many that went undetected, must
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change in order to cease proliferation, re-structure and equip the cell with all necessary
elements for the effective synthesis and secretion of milk components. While our lists of
differently regulated proteins are broad and individual proteins may be associated with
multiple roles or cell processes, this global expression data set will serve as a starting
point for future validation experiments with more specific hypotheses.

Metabolic Proteins
One group of metabolic proteins identified to change is related to the products of
glycolysis, the pentose phosphate shunt and TCA cycle. The pentose phosphate shunt is a
known driver of fatty acid production in the mammary epithelium, as NADPH is
produced providing the reducing equivalent for fatty acid synthase function (Salway,
1994). Interestingly, we observed a down regulation of transketolase in the lactating
mouse MEC, indicating a possible reduction in the use of the pentose phosphate pathway
even though we saw an increase in the abundance of fatty acid synthase. In the rodent,
NADPH can also be derived from the conversion of malate to pyruvate, termed the
malate transhydrogenation cycle, and the cleavage of isocitrate into alpha-ketoglutarate
within the cytosol. Additionally, we saw an upregulation on pyrroline-5-carboxylate
reductase 2, the action of which has also been shown to be a source of NADPH
production in the rat liver (Hagedorn, 1986). It is possible that the necessary increase in
fatty acid synthesis is being driven by the product of those reactions, while glucose is
being shunted towards lactose synthesis, glycolysis, and mitochondrial TCA cycle, rather
than the pentose phosphate pathway.
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Again, we saw a number of pyruvate-associated proteins change. One of which,
mercaptopyruvate sulfurtransferase, is an enzyme involved in cellular detoxification and
is known to be inhibited by alpha-keto acids, pyruvate and alpha-ketoglutarate. In this
experiment, we observed an up-regulation of the enzyme, which could possibly be the
response of lactating epithelium to the buildup of pyruvate and alpha-ketoglutarate.

Within the mitochondrial protein changes, we observed an upregulation of aldehyde
dehydrogenase and beta-hydroxy-butyrate dehydrogenase, which are associated with the
breakdown of acetate and beta-hydroxy butyrate to provide additional sources of acetyl
CoA, a substrate for the TCA cycle and subsequent ATP synthesis. Complementary to an
increase in acetyl CoA were the increases observed in pyruvate dehydrogenase, which is
the enzyme responsible for oxidation of pyruvate (the final product of glycolysis) into
acetyl CoA, and pyruvate carboxylase, which catalyzes the carboxylation of pyruvate to
oxaloacetate. Both oxaloacetate and acetyl CoA are necessary for the TCA cycle to
progress, producing citrate from the condensation of the two substrates catalyzed by
citrate synthase, an enzyme in which we also saw an upregulation. On a related note, the
aldehyde dehydrogenase family of proteins have been noted as markers of stem cells
within the human breast, and ALH2 specifically, one of the enzymes in which we
detected an up-regulation upon differentiation, has also been noted to change upon
differentiation in other cell types (Moreb, 2008). The aldehyde dehydrogenase family 4
member A1 protein is involved in the process of interconnecting the TCA cycle and urea
cycle (The UniProt Consortium, 2012). Although there is no known urea cycle activity in
the mammary epithelium, the up regulation of this enzyme is curious, as we saw another
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unexpected urea cycle-associated enzyme change in abundance in the MAC-T cell
differentiation experiment. This occurrence would make an interesting point for further
investigation.

The next reaction occurring in the TCA cycle is the reversible dehydration of citrate into
isocitrate catalyzed by aconitase. We did observe an increase in the abundance of
aconitase as well, which is interesting because both citrate and isocitrate may be shuttled
from the mitochondria to participate in other metabolic pathways however, cytosolic
citrate may be cleaved into oxaloacetate and acetyl CoA by the enzyme citrate lyase
while isocitrate is restricted to the fate of becoming alpha-ketoglutarate through isocitrate
dehydrogenase activity. Cytosolic isocytrate dehydrogenase abundance was down
regulated in the cells isolated from lactating mice along with the mitochondrial enzymes
alphaketoglutarate dehydrogenase, succinate dehydrogenase, serine hydroxy-methyl
transferase and phosphenolpyruvate carboxykinase (PEPCK). These enzymes, excluding
PEPCK, are associated with the TCA cycle and all catalyze steps following the
production of alpha-ketoglutarate. The combination of all of these changes indicate a
build up of citrate and isocitrate within the mitochondria, and due to the reversibility of
aconitase activity, both products may be shuttled out of the mitchondria, dependent on
metabolic demands. In this way, citrate is likely contributing to fatty acid synthesis in a
way that is not possible in the ruminant mammary epithelial cell. Not only does citrate
produce acetyl CoA as a precursor for fatty acid synthesis, but the conversion of
oxaloacetate to malate and then oxidation of malate to pyruvate, is another source of
NAPDH. Pyruvate produced in this fashion may then return to the mitchondria to
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continue the cycle. The observed down regulation of the enzyme alpha enolase, which
catalyzes the final step of glycolysis could be due to the cyclical recycling of pyruvate
through the steps described. If glucose is not being used for production of pyruvate, it
may be spared for the synthesis of lactose or converted to glycerol for milk fat.

Heat Shock Proteins
Several heat shock proteins (HSP) were identified as changing in abundance between
states of pregnancy and lactation in the isolated mammary epithelial cell populations.
HSPs are molecular chaperones that facilitate the correct folding of proteins and are
associated with function and formation of the cytoskeleton. It is not surprising that the
differentiation of the mammary epithelium, in vivo, would require structural reorganization, which may be facilitated by this family of proteins.

Cytoskeletal Proteins
Structurally, we saw a down-regulation in keratins 8 and 18, which are associated with
epithelial differentiation and filament reorganization, respectively. As differentiated cells
were isolated from mice at peak lactation, it is expected that cells would be fully
differentiated and not undergoing major structural changes they would during pregnancy
and proliferation. Coincidentally, keratin 18, or CK18, was the marker of epithelial origin
selected for use in flow cytometry (see appendix). It is interesting that we saw a downregulation of this protein, as previous studies suggested use of this antibody due to
uniform expression in luminal epithelial cells (O’Hare, 1991). Keratin 5 however, was
up-regulated, which is interesting as this is also a filament associated with the process of
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differentiation which these cells should no longer be undergoing. This change in specific
intermediate filaments is a point of differentiation that deserves deeper research.

Nuclear Proteins
Within the group of resident nuclear proteins that were identified to change, there were
seven examples of heterogeneous nuclear ribonucleoproteins (hnRNP) and all decreased
in abundance after differentiation. These particles are generally bound to pre-mRNA to
signal that the mRNA is not yet ready to be translocated to the cytoplasm. Once the
correct splicing has occurred, mature mRNA may leave the nucleus, and hnRNPs remain
bound to spliced-out introns, then signaling for degredation (Papadopoulou, 2012). The
down-regulation of every hnRNP we detected to change signifies either a reduction in the
mRNA for genes with which these specific hnRNPs are associated, or a change in the
way the differentiated cell directs splicing and mRNA processing.

Pre-mRNA processing factor 19, isoform 2, which was down regulated in the lactating
mouse mammary epithelium, was also down regulated in differentiated MAC-T cells,
indicating that this protein may play a universal role in the mammary epithelial cell
specifically during proliferation. In the mouse brain, expression of the beta isoform of the
pre-mRNA processing factor 19 gene (Prf19b) caused differentiation of neuronal cells,
but inhibited differentiation of astroglial cells indicating that alternative splicing of this
gene plays a very specific role in cell fate decision (Urano, 2006). Perhaps, this isoform
of the Prf19 gene is also required for the differentiation of mammary epithelial cells.
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CHAPTER 4 - Summary

These experiments present the same cell type from two different species utilizing very
different metabolic processes that overall, result in a very similar outcome: lactogenesis.
In other words, there are multiple routes to the same endpoint, and the pathways taken to
differentiation could possibly be determined by the diet, absorption and subsequent
nutrients available to the mammary gland.

The first experiment presented within this document compared the protein expression
profiles of MAC-T cells from before and after induced in vitro differentiation. The data
produced through this experiment supported earlier research from our lab which not only
revealed a direct effect of growth hormone on MAC-T, but suggested the effect may be
similar to the changes occurring naturally during differentiation of the cell. By observing
the changes to the proteome that occurred between proliferation and differentiation of
MAC-T cells, we not only confirmed that there are several similarities between
differentiation and GH treatment, but also uncovered a host of proteins that we did not
expect to change. The new list of identified proteins provides a great deal of novel
information about the mammary epithelium and the molecular processes that are possibly
involved in lactogenesis.

The second study was designed in attempt to provide an in vivo comparison to this
experiment, while simultaneously offering insight into the inherent differences between
mammary glands from ruminant and rodent animals. As the diets and overall metabolic

89

systems in these two species are drastically different, it is interesting to see evidence that
those differences are mirrored on the molecular level in the way mammary epithelial cells
use or spare certain nutrients, depending on availability, to efficiently synthesize all of
the essential components of milk.

While the differing proteins between primary MEC isolated before and after the initiation
of lactation provide an interesting basis for further study, it is important to remember that
the two stages at which we isolated our protein samples do not provide a progressive
picture of the changes occurring within the mammary epithelium. These data afford a
great number of possibilities for studies to be developed providing a clearer picture of
individual pathways and metabolic changes by observing additional time-points or by
employing more specific, quantitative technologies. Western blotting is an excellent tool
for measuring specific proteins of interest and would negate the challenge of missing
low-abundance proteins or misguided analysis due to post-translational modifications,
which are possible with our methods of 2D electrophoresis. However, there are added
challenges to the Western blot such as antibody specificity, difficulty identifying
important post-translational modifications and statistical analyses that would require
careful consideration. Additionally, adding other developmental stages, such as pre
versus post puberty and pre versus post established pregnancy would be interesting to
study in comparison to our findings.

Some of the data collected in these experiments has paralleled previous research in
mammary gland biology, some appears to challenge the current dogma and some has
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incited our curiosity in pathways never before explored in the mammary epithelium.
While much necessary investigation still remains to make clear the roles of certain
proteins and pathways in the evolution to a lactogenic phenotype, the analysis of these
extensive protein lists may provide a platform from which further research may be based.

91

LIST OF REFERENCES

Akers, et al., 2005 Ovarian and IGF-I axis control of mammary development in
prepubertal heifers. Domestic Animal Endocrinology 29(2): 259-267.
Ali, et al., 2001 Cellular transformation by SV40 large T antigen: interaction with host
proteins. Seminars in Cancer Biology 11(1): 15-23.
Amos, et al., 1985 Influence of milking frequency on productive and reproductive
efficiencies of dairy cows. Journal of Dairy Science 68(3): 732-739.
Anderson, et al., 2007 Secretory activation in the mammary gland: it's not just about milk
protein synthesis! Breast Cancer Research 9(1): 204.
Asselin-Labat, et al., 2010 Control of mammary stem cell function by steroid hormone
signaling. Nature 465(7299): 798-802.
Ball, et al., 1988 Prolactin regulation of beta-casein gene-expression and of a cytosolic
120-kD protein in a cloned mouse mammary epithelial-cell line. Embo Journal
7(7): 2089-2095.
Bauman, et al., 2000 Regulation of Nutrient Partitioning During Lactation: Homeostasis
and Homeorhesis Revisited. Ruminant physiology: Digestion, Metabolism,
Growth and Reproduction 311-328.
Bauman, et al., 2011 Mammary Gland, Milk Synthesis and Secretion Encyclopedia of
Dairy Sciences. Academic Press 2340-2346.
Bell and Bauman, 2000 Regulation of Macronutrient Partitioning between Maternal and
Conceptus Tissues in the Pregnant Ruminant. Ruminant Physiology: Digestion,
Metabolism, Growth and Reproduction 275-294.
Bequette, et al., 1997 Amino acid supply and metabolism by the ruminant mammary
gland. The Proceedings of the Nutrition Society 56(2): 593-605.
Berry, et al., 2001 A local increase in the mammary IGF-1: IGFBP-3 ratio mediates the
mammogenic effects of estrogen and growth hormone. Domestic Animal
Endocrinology 21(1): 39-53.
Berry, et al., 2003Interactions between the ovary and the local IGF-I axis modulate
mammary development in prepubertal heifers. The Journal of Endocrinology
177(2): 295-304.
Brackley, et al., 2011 Interactions between the actin filament capping and severing
protein gelsolin and the molecular chaperone CCT: evidence for nonclassical
substrate interactions. Cell Stress & Chaperones 16(2): 173-179.

92

Brisken, et al., 2006 Alveolar and lactogenic differentiation. Journal of Mammary Gland
Biology and Neoplasia 11(3-4): 239-248.
Bu, et al., 2011 Keratin 6a marks mammary bipotential progenitor cells that can give rise
to a unique tumor model resembling human normal-like breast cancer. Oncogene
30(43): 4399-4409.
Capuco, et al., 2002 Postnatal mammary ductal growth: three-dimensional imaging of
cell proliferation, effects of estrogen treatment, and expression of steroid
receptors in prepubertal calves. Tissue & Cell 34(3): 143-154.
Chew, et al., 2000 The LIM and SH3 domain-containing protein, lasp-1, may link the
cAMP signaling pathway with dynamic membrane restructuring activities in ion
transporting epithelia. Journal of Cell Science 113(11): 2035-2045.
Coll, et al., 1995 Targeted distribution of viniculin genes in F9 and embryonic stem-cells
changes cell morphology, adhesion and locomotion. Proceedings of the National
Academy of Sciences of the United States of America 92(20): 9161-9165.
Creutz, et al., 1992 The annexins and exocytosis. Science 258(5084): 924-931.
Danielson, et al., 1984 Epithelial mouse mammary cell line exhibiting normal
morphogenesis in vivo and functional differentiation in vitro. Proceedings of the
National Academy of Sciences of the United States of America 81(12): 37563760.
Delamaire, et al., 2006 Longer milking intervals alter mammary epithelial permeability
and the udder's ability to extract nutrients. Journal of Dairy Science. 89(6): 20072016.
Desrivieres, et al., 2003 Comparative proteomic analysis of proliferating and functionally
differentiated mammary epithelial cells. Molecular & Cellular Proteomics 2(10):
1039-1054.
Elis, et al., 2011 Unbound (bioavailable) IGF1 enhances somatic growth. Disease Models
& Mechanisms 4(5): 649-658.
Etherton, et al., 1998 Biology of somatotropin in growth and lactation of domestic
animals. Physiol Rev 78(3): 745-761.
Foster, et al., 1977 Changes in mouse mammary epithelial-cell size during mammarygland development. Cell Differentiation 6(1): 1-8.
Gadkar-Sable, et al., 2005 Progesterone receptors: various forms and functions in
reproductive tissues. Front Bioscience 10: 2118-2130.
Gallego, et al., 2001 Prolactin, growth hormone, and epidermal growth factor activate
stat5 in different compartments of mammary tissue and exert different and

93

overlapping developmental effects. Developmental Biology 229(1): 163-175.
Gjoevski, et al., 2011 Integrated morphodynamic signalling of the mammary gland.
Nature Reviews Molecular Cell Biology 12(9): 581-593.
Gnoni, et al., 2009 Quercetin inhibits fatty acid and triacylglycerol synthesis in rat-liver
cells. European Journal of Clinical Investigation 39(9): 761-768.
Guinard-Flament, et al., 2006 Changes in mammary uptake and metabolic fate of glucose
with once-daily milking and feed restriction in dairy cows. Reproduction,
Nutrition, and Development 46(5): 589-598.
Hagedorn, et al., 1986 Demonstration of a NADPH-linked delta 1-pyrroline-5carboxylate-proline shuttle in a cell-free rat liver system. Biochimica et
Biophysica Acta 884(1): 11-17.
Haines, et al., 2011 Argininosuccinate synthase: at the center of arginine metabolism.
International Journal of Biochemistry and Molecular Biology 2(1): 8-23.
Haug, et al., 2007 Bovine milk in human nutrition--a review. Lipids in Health and
Disease (6): 25.
Hens, et al., 2005 Key stages of mammary gland development: molecular mechanisms
involved in the formation of the embryonic mammary gland. Breast Cancer
Research 7(5): 220-224.
Hovey, et al., 1998 The proliferation of mouse mammary epithelial cells in response to
specific mitogens is modulated by the mammary fat pad in vitro. In Vitro Cellular
& Developmental Biology. Animal 34(5): 385-392.
Hovey, et al., 1999 Regulation of mammary gland growth and morphogenesis by the
mammary fat pad: A species comparison. Journal of Mammary Gland Biology
and Neoplasia 4(1): 53-68.
Huynh, et al., 1991 Establishment of bovine mammary epithelial cells (MAC-T): an in
vitro model for bovine lactation. Experimental Cell Research 197(2): 191-199.
Jenness, et al., 1979 The composition of human milk. Seminars in Perinatology 3(3):
225-239.
Johnson , et al., 2010 Growth hormone alters lipid composition and increases the
abundance of casein and lactalbumin mRNA in the MAC-T cell line. Journal of
Dairy Research 77: 199-204.
Kaulsay et al., 2001 The effects of autocrine human growth hormone (hGH) on human
mammary carcinoma cell behavior are mediated via the hGH receptor.
Endocrinology 142(2): 767-777.

94

Keys, et al., 1997 Bovine mammary explant versus primary cell cultures: effect of bovine
somatotropin and insulin-like growth factor-I on DNA content and protein
synthesis. In Vitro Cellular & Developmental Biology. Animal 33(3): 206-211.
Knight, et al., 1982 Mammary cell proliferation in mice during pregnancy and lactation in
relation to milk yield. Quarterly Journal of Experimental Physiology 67(1): 165177.
Knight, et al., 2001 Overview of prolactin's role in farm animal lactation. Livestock
Production Science 70(1-2): 87-93.
Kuhla, et al., 2011 Involvement of Skeletal Muscle Protein, Glycogen, and Fat
Metabolism in the Adaptation on Early Lactation of Dairy Cows. Journal of
Proteome Research 10(9): 4252-4262.
Laliotis, et al., 2010 Comparative Approach of the de novo Fatty Acid Synthesis
(Lipogenesis) between Ruminant and Non Ruminant Mammalian Species: From
Biochemical Level to the Main Regulatory Lipogenic Genes. Current Genomics
11(3): 168-183.
Larson, et al., 1979 Biosynthesis and secretion of milk proteins: a review. The Journal of
Dairy Research 46(2): 161-74.
Lecchi, et al., 2012 Widespread expression of SAA and Hp RNA in bovine tissues after
evaluation of suitable reference genes. Veterinary Immunology and
Immunopathology 145(1-2): 556-562.
Levine, et al., 2010 The control of the metabolic switch in cancers by oncogenes and
tumor suppressor genes. Science 330(6009): 1340-1344.
Lollivier, et al., 2006 Oxytocin stimulates secretory processes in lactating rabbit
mammary epithelial cells. The Journal of Physiology 570(1): 125-140.
MacMahon, et al., 1970 Age at first birth and breast cancer risk. Bulletin of the World
Health Organization 43(2): 209-221.
Matitashvili, et al., 1997 An in vitro approach to ruminant mammary gland biology.
Biotechnology Advances 15(1): 17-41.
Mayanagi, et al., 2011 Diversification of caldesmon-linked actin cytoskeleton in cell
motility. Cell Adhesion & Migration 5(2): 150-159.
Mellenberger, et al., 2009 Metabolic adaptations during lactogenesis: fatty acid and
lactose synthesis in cow mammary tissue. Journal of Mammary Gland Biology
and Neoplasia 14(3): 261-268.
Miriam-Webster, 2012 "mammal" definition. Online Dictionary http://www.merriamwebster.com/dictionary/mammal

95

Moffat, et al., 1999 Structure and expression of the mouse growth hormone
receptor/growth hormone binding protein gene. Journal of Molecular
Endocrinology 23(1): 33-44.
Mol, et al., 1995 Growth hormone messenger mRNA in mammary gland tumors of dogs
and cats. Journal of Clinical Investigation 95(5): 2028-2034.
Moreb, et al., 2008 Aldehyde dehydrogenase as a marker for stem cells. Current Stem
Cell Research Theory 3(4): 237-246.
Moriera, et al., 2010 Lapatinib and breast cancer: current indications and outlook for the
future. Expert Review of Anticancer Therapy 10(8): 1171-1182.
Morishita, et al., 1996 Effect of dietary corn oil, butter and beef tallow on the cecal
microflora and short-chain fatty acids in rats. Bioscience and Microflora 15(1):
27-30.
Mukhina, et al., 2006 Autocrine growth hormone prevents lactogenic differentiation of
mouse mammary epithelial cells. Journal of Endocrinology 147(4): 1819-1829.
Ng, et al., 1997 Growth hormone treatment induces mammary gland hyperplasia in aging
primates. Nature Medicine 3(10): 1141-1144.
NIH (National Institute of Health), 2011 Biomarkers NIEHS – NIH website
http://www.niehs.nih.gov/health/topics/science/biomarkers/index.cfm
O'Hare, et al., 1991 Characterization in vitro of luminal and myoepithelial cells isolated
from the human mammary gland by cell sorting. Differentiation; Research in
Biological Diversity 46(3): 209-221.
O'Quinn, et al., 2002 Arginine catabolism in lactating porcine mammary tissue. Journal
of Animal Science 80(20): 467-474.
Ou, et al., 2008 Novel breast cancer biomarkers identified by integrative proteomic and
gene expression mapping. Journal of Proteome Research 7(4): 1518-1528.
Papadopoulou, et al., 2012 Expression profile and interactions of hnRNP A3
within hnRNP/mRNP complexes in mammals. Archives of biochemistry and
biophysics 523(2): 151-160.
Perry, et al., 2008 The contribution of growth hormone to mammary neoplasia. Journal of
Mammary Gland Biology and Neoplasia 13(1): 131-145.
Picciano, et al., 2003 Pregnancy and lactation: physiological adjustments, nutritional
requirements and the role of dietary supplements. The Journal of Nutrition 133(6):
1997-2002.
Puckelwartz, et al., 2011 Gene expression, chromosome position and lamin A/C

96

mutations. Nucleus 2(3): 162-167.
Raccurt, et al., 2002 High stromal and epithelial human GH gene expression is associated
with proliferative disorders of the mammary gland. Journal of Endocrinology
175(2): 307-318.
Rhoads, et al., 2007 Translational regulation of milk protein synthesis at secretory
activation Journal of Mammary Gland Biology and Neoplasia 12(4): 283-292.
Rius, et al., 2010 Regulation of protein synthesis in mammary glands of lactating dairy
cows by starch and amino acids. Journal of Dairy Science 93(7): 3114-3127.
Rowling, et al., 1994 A single purification procedure for resident proteins of the ER
lumen. Protein Expression and Purification 5(4): 331-336.
Rudolph, et al., 2011 Prolactin-mediated regulation of lipid biosynthesis genes in vivo in
the lactating mammary epithelial cell. Endocrinology and Metabolism 300(6):
1059-1068.
Russo, et al., 2005 The protective role of pregnancy in breast cancer. Breast Cancer
Research 7(3): 131-142.
Salway, JG, 1994 Metabolism at a Glance. Blackwell Publishing, Ltd.
Saotome, et al., 2004 Ezrin is essential for epithelial organization and villus
morphogenesis in the developing intestine. Developmental Cell 6(6): 855-864.
Shackleton, et al., 2006 Generation of a functional mammary gland from a single stem
cell. Nature 439(7072): 84-88.
Shaper, et al., 1998 Beta1,4-galactosyltransferase and lactose biosynthesis: recruitment of
a housekeeping gene from the nonmammalian vertebrate gene pool for a
mammary gland specific function. Journal of Mammary Gland Biology and
Neoplasia 3(3): 315-324.
Shoyab, et al., 1989 Structure and function of human amphiregulin: a member of the
epidermal growth factor family. Science 243(4894): 1074-1076.
Shyamala, et al., 2002 Cellular expression of estrogen and progesterone receptors in
mammary glands: regulation by hormones, development and aging. The Journal
of Steroid Biochemistry and Molecular Biology 80(2): 137-148.
Siewit, et al., 2009 Cadmium Promotes Breast Cancer Cell Proliferation by Potentiating
the Interaction between ER alpha and c-Jun. Molecular Endocrinology 24(5):
981-992.
Smalley, MJ, 2010 Isolation, culture and analysis of mouse mammary epithelial cells.
Methods Molecular Biology 633: 139-70.

97

Stingl, et al., 2011 Estrogen and progesterone in normal mammary gland development
and in cancer. Hormones & Cancer 2(2): 85-90.
Sunehag , et al., 2003 Contribution of plasma galactose and glucose to milk lactose
synthesis during galactose ingestion. The Journal of Clinical Endocrinology and
Metabolism 88(1): 225-229.
Telang, et al., 1989 In vitro biotransformation of estradiol by explant cultures of murine
mammary tissues. Breast Cancer Research and Treatment 13(2): 173-181.
The UniProt Consortium, 2012 Reorganizing the protein space at the Universal Protein
Resource (UniProt). Nucleic Acids Research 40: D71-D75.
Trott, et al., 2009 Tissue-specific regulation of porcine prolactin receptor expression by
estrogen, progesterone, and prolactin. Journal of Endocrinology 202(1): 153-166.
Tucker, et al., 1981 Physiological control of mammary growth, lactogenesis, and
lactation. Journal of Dairy Science 64(6): 1403-1421.
Urano, et al., 2006 Involvement of the mouse Prp19 gene in neuronal/astroglial cell fate
decisions. The Journal of Biological Chemistry 281(11): 7498-7514.
Van Soest, 1994 Nutritional Ecology of the Ruminant. Cornell University Press.
Visvader, et al., 2009 Keeping abreast of the mammary epithelial hierarchy and breast
tumorigenesis. Genes & Development 23(22): 2563-2577.
Xu, et al., 2011 Growth hormone signaling in human T47D breast cancer cells: potential
role for a growth hormone receptor-prolactin receptor complex. Molecular
Endocrinology 25(4): 597-610.
Yogi, et al., 2012 Mammary gland morphological and gene expression changes
underlying pregnancy protection of breast cancer tumorigenesis. Physiological
Genomics 44(1): 76-88.
Zavizion, et al., 1995 Subcloning the MAC-T bovine mammary epithelial cell line:
morphology, growth properties, and cytogenic analysis of clonal cells. Journal of
Dairy Science 78(3): 515-527.
Zhao, et al., 1996 Localization and gene expression of glucose transporters in bovine
mammary gland. Comparative Biochemistry and Physiology Part B: Biochemistry
and Molecular Biology 15(1): 127-134.
Zhou, et al., 2008 Growth hormone can induce expression of four major milk protein
genes in transfected MAC-T cells. Journal of Dairy Science 91(1): 100-108.
Zhu, et al., 2011 Prognostic Evaluation of CapG, Gelsolin, P-gp, GSTP1, and Topo-II
Proteins in Non-Small Cell Lung Cancer. Anatomical Record-Advances in

98

Integrative Anatomy and Evolutionary Biology 295(2): 208-214.

99

APPENDIX
Flow Cytometry
Although we attempted to verify the epithelial origin of primary cells isolated from
pregnant and lactating mice through application of flow cytometry, our efforts were
relatively unsuccessful. Cytokeratin 18 (CK18) was selected as a positive marker as it is a
cytoskeletal filament associated specifically with luminal-epithelial cells and not
squamous, myoepithelial cells or fibroblasts which are possible contaminating cell types
in a primary mammary epithelial cell isolation such as this one (O’Hare, 1991).
Additionally, CK18 and had previously been demonstrated to be uniformly expressed by
MAC-T populations (Zavizion, 1995).

A FITC-conjugated primary anti-mouse CK18 antibody was purchased from Abcam
(Cambridge, MA).

Primary cells isolated for proteomic analysis from pregnant and lactating mice were
thawed from storage in liquid nitrogen. Additionally, HC11 cells (an immortal mouse
mammary epithelial cell line) were thawed and used as a positive control. 3T3 cells were
selected as a negative control as this fibroblast cell line is murine in origin, but should not
express CK18. Remaining cells were fixed and permeabilized through incubation in
100% methanol at -20°C for 30 minutes. Cells were then centrifuged and rinsed in PBS.
CK18 antibody was diluted from 100ug/ml to 10ug/ml in 3% Bovine Serum Albumin
(BSA) and then to a final concentration of 1ug/ml in cell suspension. All cells were
incubated in the dark at 4°C for 30 minutes. Control cells of each variety were incubated
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simultaneously under the same conditions with an equal volume of 3% BSA containing
no antibody. After incubation, cells were washed 3x through centrifugation at 400 x g for
5 minutes in PBS. Each pellet was diluted to a final concentration of <500 cells/ul before
analysis by flow cytometry. Levels of florescence emitted by each cell corresponded with
the expression of CK18. Fluorescence data between cell types was overlaid and
compared with viability counts to estimate the percentage of epithelial cells isolated.
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Results
A.

B.

Figure ___. Cells isolated from pregnant mice that were (A) plated overnight were 87%
viable and stained positively with CK18 FITC conjugated antibody (solid peaks) as
compared to the negative control (3T3 fibroblasts), overlaid in the image. (B) Cells tested
tes
directly after thawed from liquid N were only 40% viable and consequently, less
fluorescence was measured as compared to the negative control.
A.

B.

Figure ___. Cells isolated from lactating mice that were (A) plated overnight were 78%
viablee and stained positively with CK18 FITC conjugated antibody (solid peaks) as
compared to the negative control (3T3 fibroblasts), as shown by the dark line overlaid in
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the image. The lighter overlay represents two peaks of fluorescence of the cells from
pregnant mice after the same culture period. (B) Cells tested directly after thawed from
liquid N were only 41% viable and consequently, less fluorescence was measured as
compared to the negative control.
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